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Abstract
Pyridoxal 5-phosphate dependent aspartate aminotransferase catalyses the conversion 
of (2S)-aspartic acid and a-ketoglutaric acid into (2S)-glutamic acid and oxaloacetate. 
Both the mono and dimethylesters of (2S)-aspartic acid, together with the 
corresponding amides were synthesised in order to assess the influence of charge 
neutralisation of the a-amino pK of aspartate bound to aspartate aminotransferase. A 
novel method was developed for the synthesis of the (25)-aspartic acid a-methylester 
(57) starting from the (3-allyl ester of aspartic acid. The required ester (57) was 
obtained in 25% yield over 4 steps. pKa Studies carried out in collaboration with Profs. 
Schnackerz and Cook, have revealed that, although both of the carboxylates of 
aspartate form hydrogen-bonds to Arg-292 and Arg-386, upon binding to the enzyme, 
charge is not completely neutralised at either of the two.
Glutamate 1-semialdehyde aminomutase is an exceptional PLP-dependent enzyme in 
that, although it is classified as a mutase (transfering amino and oxo functions within 
the molecule) it functions as an aminotransferase. We have devised a new route to 2,3- 
diaminopropyl hydrogen sulfate, a substrate/ inhibitor which should shed more light on 
the mechanism of this enzyme. The key steps in the synthesis were the conversion of 
the amide (68) into the amine (69) using the Waki modification of the Hoffman 
reaction and reduction of the a-carboxylate into the primary alcohol (53). Sulfation of 
the diamino alcohol (66) using chlorosulfonic acid in DCM gave the required sulfate 
(56), contaminated with upto 20% of starting material. The material was purified by 
ion exchange chromatography and was used in kinetic studies in the laboratory of Prof. 
R. John.
We have also attempted to develop a new synthetic route to 3-[2H]-(2S)-serine starting 
from (2S)-aspartic acid. This compound should be useful in delineating the mechanism 
of a number of other PLP-dependent enzymes. Although we have synthesised a 
number of Baeyer-Villiger precursors we have been unable to find conditions in which 
the oxidation proceeds in more than 20% yield.
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INTRODUCTION
Introduction
1.0. Introduction
Pyridoxal 5’-phosphate (PLP, 1), the biologically active form of vitamin B6 
(Pyridoxol, 2) is one of the nature's most versatile co-enzymes and serves as a cofactor 
for a myriad of enzyme-catalyzed reactions, many of which are essential for amino acid 
metabolism. The enzymes have several common mechanistic and stereochemical 
features. In the mid 1940's Snell1 identified PLP as the coenzyme for transaminases, 
and since then, PLP has been established as the coenzyme for over 20 different types of 
enzyme catalysed reactions.
(1 ) (2)
PLP is the required cofactor for enzymes integral in connecting the carbon and nitrogen 
cycles. The coenzyme is also involved in the formation of biogenic amines and in 
providing entry into the “one-carbon pool”. The fact that PLP dependent enzymes 
occur in four of the six EC classes reflects its versatility.2
Experimental B6 deficiency in animals results in vitamin B$ pellagra, characterized by 
loss of hair, edema and red, scaly skin. Deficiency inhibits the degradation of (25)- 
tryptophan, and the excretion of xanthurenic acid, a product of PLP-dependent 
tryptophan catabolism) is used as an index of vitamin B$ deficiency.
1
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1.1 Metabolic role of PLP dependent enzymes
There has been a great deal of interest in understanding the mechanism of action of 
PLP dependent enzymes because of the important role they play in many physiological 
processes. Some illustrative examples are discussed below.
y-Aminobutyric transaminase (GABA-T) is involved in the regulation of the GABA-
ergic system3 in the mammalian central nervous system (CNS) (Scheme 1.1). 
y-Aminobutyric acid (GABA) is a inhibitory neurotransmitter and there is much 
evidence to suggest that high cerebral concentrations of this compound prevent 
convulsions, by depressing the firing of neurons throughout the CNS.
NH2
H * k ^ r n „ ---------------- .
C02H 2 decarboxylase
Glutamate n h 2
H i k ^
H C02H
Receptor occupation
(2S)-Glutamic acid 
O
H0 2C-'1k / ^ c02H 
a-Ketoglutaric acid
J GABA-T
via
intermediates 
in the citric 
acid cycle
\
\
O
C02H
Succinic acid semi aldehyde
, ^ ^ c o 2H
ho2c
Succinic acid HO
Scheme 1.1: The OABA-ergic system.
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co-Omithine transaminase not only interconnects the citric acid cycle and urea cycle but 
also couples ornithine to proline metabolism (Scheme 1.2).4
NH2
N'V '
H°2 °  . . .  NH2
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NH2
nh2 o
t
nh2
HOaC HO2C
Ornithine
1
NH2 t  h 
H02C »
NH2
0  O
via HC^ C 
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acid a-Ketoglutaric acid
cycle
CO2H
H N ^ \
H")
HOgC
J k /
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N ^ \
ho2c
Oxidation
NH2
COoHH02C
Scheme 1.2: 77?<? metabolic significance of ornithine transaminase.
The aminomutase, glutamate 1-semialdehyde aminomutase (GSA-AM), also called 
glutamate 1-semialdehyde aminotransferase (GSA-AT) catalyses the formation of 6 - 
aminolevulinate (see Schemes 1.8 and 1.9; p. 16-20), and it is the last enzyme in the t- 
RNAGlu-mediated pathway that produces 5-aminolevulinate for the synthesis of 
chlorophyll, heme, and other tetrapyirole pigments.5
One of the most important physiological roles of the decarboxylases in mammals is the 
conversion of amino acids to pharmacologically active amines.6 The formation of- 
dopamine, histamine, GABA, and putrescine all depend on PLP-dependent 
decarboxylation of their respective parent amino acids. The biosynthesis of higher
3
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polyamines, spermine and spermidine, from putrescine involve the pyruvate-dependent 
decarboxylation of S-adenosyl methionine (SAM). Mammalian brain glutamate 
decarboxylase is directly responsible for the biosynthesis of GAB A in the GAB A-ergic 
system (Scheme l . l ) .3
Ornithine decarboxylase (ODC) is the first and rate limiting enzyme in the biosynthetic 
pathway leading to putrescine and higher polyamines (Scheme 1.3).4 The activity of 
the enzyme in vivo increases dramatically in response to cellular stimulation which 
promotes regeneration and replication. Cellular levels of the enzyme are high during 
growth, and low at other stages.7 The association of high polyamine levels with rapid 
cellular proliferation and protein biosynthesis, led to the idea that polyamines may be 
required for RNA/DNA biosynthesis.8 The enzyme has been identified as a target for 
cancer chemotherapy.4
Scheme 1.3: The synthesis of higher polyamines.
Histidine decarboxylase (HDC) catalyses the decarboxylation of histidine to give
I
histamine. In mammals, histidine is important as the major receptor agonist.9 
Overproduction of histamine is associated with many biological processes including 
gastric secretion, allergic and hypersensitivity reactions. 10 The development of
4
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antihistamines (antagonists for the receptors), has been an important area in medicinal 
chemistry. Histamine is also active as a regulator of peripheral blood circulation.10 
The aromatic amino acid decarboxylases catalyse the formation of many 
pharmacologically important amines. For example, DOPA decarboxylase is able to 
convert many aromatic substrates to the corresponding amines including, phenylalanine
(3) to phenylethylamine (4), tyrosine (5) to tyramine (6 ), tryptophan (7) to tryptamine 
(8 ), histidine (9) to histamine (10), 3,4-dihydroxyphenylalanine (DOPA) (11) to 3,4- 
dihydroxyphenylethylamine (dopamine) (12) and 5-hydroxytrytophan (13) to 
serotonin (14), Table l . l .11 Dopamine and serotonin act on smooth muscles and the 
cardiovascular system. Dopamine is a precursor in the biosynthesis of adrenaline and 
serotonin itself is neuroactive.10
Another important class of PLP dependent enzymes, the racemases, catalyses the 
interconversion of (2/?)- and (2S)- amino acids. These enzymes are common in the 
prokaryotes and several are involved in the biosynthesis of peptidoglycan in bacterial 
cell walls.12 Alanine racemase is an important enzyme in peptidoglycan biosynthesis 
and therefore is a target for the action of many antibacterial agents, 13 including (2R)- 
cycloserine (15)15, 0-carbamyl-(2/?)-serine (16) and phosphoalanine (17).13
i
5
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Table 1.1: Some of the aromatic substrates decarboxylated by DOPA decarboxylase
Substrate Product am ine
ho2c
(3)
xo
H
(4)
XCr”
ho2c
(5)
x a ”
H
(6)
n h 2 V = (
l+ ^ k ^ ^ S /N H
ho2c
(7)
n h2
H
(8)
2 H 
(9)
-AO 
(10) H
OHXJb"0"
h o 2c
(11)
OH
n h2
(12)
n h 2
ho2c
(13)
n h 2 V = (
H-*yvs-^ 5 s / NH
H
(14)
f
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1.2 Structure and mechanism of PLP dependent enzymes
The general theory of the PLP mediated amino acid reactions was developed 
independently by Braunstein and Snell in 1953-54.15,16 The co-enzyme PLP, is bound 
at the active site as a Schiff s base complex (18) with the e-amino group of an active 
site lysine residue (Scheme 1.4) . 17-19 Introduction of the substrate leads to a 
transaldimination reaction which frees the active site lysine residue and leads to the 
formation of another Schiff s base, substrate aldimine (19) (Scheme 1.4). For some 
enzymic systems the transaldimination reaction causes a large conformational change in 
the conformation of the co-enzyme complex at the active site of the enzyme.
Enz Enz
Substrate
F r'" '-f? ccr2
transaldimination
Holoenzyme aldimine 
(18) (19)
3
Ca-H cleavage
EnZV ^ V -f jH 3
fT V co~2
Products
Scheme 1.4: PLP and the conjugated electron-deficient n-electron system shown for 
the removal ofCa-Hfrom a (2S)-amino acid.
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In the presence of the appropriate enzyme, all of the bonds connected to the Ca of the 
imino acid moiety can be cleaved
Dunathan20 proposed that after formation of the enzyme-substrate Schiff s base 
complex (19) the torsional angle about the N-Ca bond is fixed by the enzyme so that 
the bond to be cleaved at Ca is held at 90° to the plane of the pyridinium ring. In this 
conformation, maximum orbital overlap is achieved between the developing charge and 
the conjugated electron-deficient jt-electron system (Scheme 1.4). The cleavage is 
further facilitated by an enzyme-bound base, usually the e-amino group of the lysyl 
residue, which stabilize the positive charge as it forms on the electrofuge, in this case a 
proton. Thus the PLP dependent enzymic reactions vary depending on which of the 
bonds at Ca is to be cleaved (Scheme 1.5).
>
8
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Scheme 1.5: Preferential cleavage of the bond orthogonal to the plane of the 
pyridinium ring, as predicted by the Dunathan hypothesis. This example shows Ca- 
CH2OH cleavage, but Ca-C02~ and Ca-H bond cleavage (i.e. decarboxylation and 
transamination/racemisation reactions respectively) can also occur.
1.3 Reactions at the oc-Carbons
1.3.1 Transamination
Transaminases (aminotransferases) are the best studied examples of of PLP-dependent 
enzymes.21 They catalyse the interconversion of pairs of amino acids and a-keto acids 
in two half reactions.
/
In the first half reaction (Scheme 1.6a), the Ca proton of the aldimine 19 is transferred 
to the ketimine (20) at the C-4'-Si face to give the pyridoxamine (PMP, 21) and an oc-
9
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keto acid (oxaloacetate). The second half of this transamination involves reaction of 
PMP (21) with another a-keto acid (e.g. a-keto glutarate) to give the ketimine (22).
1 ,3 -Suprafacial proton transfer from the C-4'-Si face then gives the aldimine (23) 
which subsequently undergoes transaldimination to give a new (2S)-amino acid, (25)- 
glutamate and the internal PLP-aldimine 18 (Scheme 1.6b).
Eiiz-NH2
c ° 2
y - H
H
(19)
h °2Cy ^ C02H
O
0 2C ^ V c Oi
hk /N--,
PO
\ J \ \
ch3
' ° 2C^ i T
co2
PMP (21) (20)
Scheme 1.6a: The first half reaction catalysed by aspartate aminotransferase.
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Enz-NHfe
ho2c.
O
CO2H
PMP, (21)
Enz-NH2
H
(23)
♦
1
Enz
(18)
Enz-NH2
PO
° 2c - < r r C02“
i+ A - n- h
Enz-f5H2
NI
H
(22)IA
“02C col
H
ho 2c^ ^ c o 2h
nh2
Scheme 1.6b: The second half reaction catalysed by aspartate aminotransferase. 
Aspartate aminotransferase (AAT) has received by far the most attention.22' 24 It
t
catalyses the conversion of (2S)-aspartic acid and a-ketoglutaric acid to (25)-glutamic 
acid and oxaloacetate. X-Ray structures of the active holoenzyme substrate complex 
have been published for chicken mitochondrial AAT,25 pig cytosolic AAT,26 and
11
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chicken heart cytosolic AAT27 at 2.8 A. More recently the crystal structure of E. coli 
AAT has been determined,28 and the overall folding of the protein was found to be 
similar to that of the mammalian enzymes.
Arigoni and Besmer, 18 and Dunathan et a/ . 19’29 independently studied the 
aminotransferase reaction. They discovered that although pyridoxal was a co-enzyme 
for the reaction, it did not bind to the apoenzyme as tightly as PLP. Both groups of 
researchers demonstrated that the removal of the proton from C-4' occurs from the 4'- 
si-face of the pyridoxamine. For the transamination catalysed by pyridoxamine 
pyruvate transaminase, it was shown that direct internal hydrogen transfer occurred 
between Ca of (2S)-alanine and C-4' of the co-enzyme suggesting that the protonation 
and deprotonation occur via a suprafacial mechanism mediated by a single base.
X-Ray crystallographic studies of mitochondrial chicken heart AAT identified the active 
site residues that are important for binding PLP and the substrate (Scheme 1.7). The 
protonated nitrogen of the pyridinium ring of the coenzyme forms a hydrogen bond 
with Asp-222, whilst the deprotonated phenolic hydroxyl is hydrogen bonded to the 
Tyr-225. The 2-methyl group lies in a pocket defined by eight amino acids. The 5'- 
phosphate ester is hydrogen bonded within a hydrophilic pocket to six amino acids, 
including Ser-255 and Arg-266. Arg-266 neutralises the dianionic phosphate. The 
proximal and distal carboxylate groups of the physiological substrates are bound by 
Arg-386 and Arg-292 respectively.
The acid-base mechanism proposed for aspartate aminotransferase suggests that L- 
aspartate binds with its a-amino group protonated, and that one of the a-amine protons 
is abstracted by the Schiff base between Lys-258 and the active site PLP.30 It was 
further proposed that upon binding of the aspartate, the pKa value of its a-amino group 
decreases from a value of 9.8 to about 8 , and the Schiffs base nitrogen pKa
12
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HH,
\
Asp-222 ^ — Asp-222
O °
Scheme 1.7: Residues at the active site of chicken mitochondrial aspartate
aminotransferase.
value increases from 6  to 8 .31 The resulting matched thermodynamics between the a- 
amine and Schiff base nitrogen thus facilitates the initial proton transfer and thereby the 
overall rate of the aminotransferase reaction. Experimentally determined pKa values of 
the a-amino group of the aspartate and some of its analogues substituted at the a- 
and/or (3-carboxylate and their calculated proton affinities, along with estimated proton 
affinities of complexes in which guanidinium is hydrogen-bonded to the carboxylates 
of aspartate, and for the L-aspartate Michaelis complex of aspartate aminotransferase 
agree with the above proposal. The decrease in the pKa value of the a-amine of 
aspartate has been proposed to result from the neutralization of the charge of its a-
13
Introduction
and/or p-carboxylate.31 The extent of charge neutralization that would result in the 
proposed pKa value decrease, and whether at the a- or p-carboxylates or both is not 
known. The interaction of the aspartate a- and p- carboxylates at the active site of 
aspartate aminotransferase is via hydrogen-bonds to Arg-292 and Arg-386.32 These 
studies have improved the understanding of the conformational changes which occur in 
protein binding.12
Aspartate aminotransferase consists of two identical subunits each consisting of two 
domains. The co-enzyme is bound to the larger domain and is situated in an open 
pocket near the subunit interface which is made up of residues from both subunits. The 
two carboxylate groups of the dicarboxylic acid substrates are bound to Arg-386 and 
Arg-292 from adjacent subunits, and the substrate specificity is determined by these 
interactions. The stabilization provided by these interactions not only positions the 
substrate correctly for efficient catalysis but also shifts the conformational equilibrium 
to the closed form which brings Arg-386 3A closer to the co-enzyme which is rigidly 
positioned in the smaller domain. Transaldimination of the e-amino group of Lys-258 
by the a-amino group of the substrate to form the external aldimine is accompanied by 
a tilting of the coenzyme by ~30°. The released e-amino group of Lys-258 then serves 
as a proton donor/acceptor in the 1,3-prototropic shifts accompanying transamination. 
At this stage or after formation and hydrolysis of the initial ketimine, the co-enzyme 
rotates back by ~20°. Through out this process, the pyridinium ring is hydrogen 
bonded to the p-carboxylate group of Asp-222.
Two genetically distinct isoenzymes exist in animal tisssue, cytosolic (cAAT) and 
mitocondrial (mAAT) .33 The primary structures of a number of AAT's have been
completely elucidated 21 The amino acid sequence of mAAT's from chicken, pig, rat,
>
mouse, horse and human and of cAAT’s from chicken, pig, mouse and horse are 
known as well as those from E. coli B and E. coli K12.34 In general the mAAT’s from 
different sources show -85% sequence identity.
14
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Similiar identity is also found between cAAT’s. However the sequence identity 
between two isozymes of the same species is only about 45% .35 It should be noted 
that in all the above examples there is almost 100% identity for the region of the protein 
corresponding to substrate or co-enzyme binding sites. The active enzyme, as stated 
above is a dimer of two identical subunits (Mr 45000 Daltons)36 and contains two 
independent active sites.37*38 A comparison of the amino acid sequence for selected 
regions of AAT isoenzymes39 and the amino acid sequences for the Schiffs base 
forming region of several AAT’s40 are shown in Table 1.2 and 1.3.
Table 1.2: Comparison of the amino acid seqences for selected regions of AAT isozymes.
Isoenzyme Amino acid residue number
Source 70 108 140 190 222 258 266 292 360 386
* * k k * * k * k k
Human (mit.) EYL SGTG TWGNH LHACAHNPTG FFDMAYQGF QSYAKN ERN IRP MFC GRI
Chicken (mit.' EYL SGTG SWGNH LHACAHNPTG YFDMAYQGF QSYAKN ERA IRP MFC GRI
Pig (mit.) EYL SGTG SWGNH LHACAHNPTG FFDMAYQGF QSYAKN ERV IRP MFC GRI
Rat (mit.) EYL SGTG SGGNH LHACAHNPTG FFDMAYQGF QSYAKN ERV IRP MFC GRI
Chiken (cyt.) EYL GGTG TWENH LHACAHNPTG FFDSAYQGF QSFSKN ERV VRT MFS GRI
Pig (cyt.) EYL GGTG TWENH LHACAHNPTG FFDSAYQGF QSFSKN ERV VRV MFS GRI
E. coli NYL GGTG SWPNH FHGCCHNPTG LFDFAYQGF SSYSKN ERV IRA DFS BRV
* Corresponds to the numbered residue, the residues are numbered according to the 
sequence for cytosolic pig AAT.
15
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Table 1.3: The Setoff's base forming regions of several isozymes.
Isoenzyme
Source
Amino acid source
E. coli I V A S S Y S K N F G L Y
Chicken (mit.) V L S Q S Y A K N M G L Y
Turkey (mit.) V L S Q S Y A K N M G L Y
Pig (mit .) c L C Q s Y A K N M G L Y
Rat (mit .) c L C Q s Y A K N M G L Y
Human (mit.) c L C Q s Y A K N M G L Y
Chicken (cyt.) F C A Q s F S K N F G L Y
Pig (cyt .) F C A 9 s F S K N F G L Y
K-lysine which forms the Schiffs base
1.3.2 Glutamate 1-Semialdehyde Aminomutase
Glutamate 1-semialdehyde 2,1-aminomutase (GSA-AM) , EC 5.4.3.82 (glutamate 1- 
semialdehyde aminotransferase (GSA-AT)) is an exeptional enzyme among the 
transaminase because it catalyses the net transfer of the 2 -amino group of glutamate 1- 
semialdehyde (GSA) (24) to the 1-position to give 5-aminolevulinic acid (ALA) (30), 
Scheme 1.8.
nh2
f °
GSA-AM
________________
0
f °
H OH OH
GSA (24)
I
ALA (30)
Scheme 1.8: Reaction catalysed by glutamate 1-semialdehyde aminomutase.
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Although, the enzyme functions as a mutase, but based on structural,41 spectroscopic42 
and steady state kinetic data43 it can also belong to the family of aminotransferases and 
the mechanism for the amino group transfer is comparable to that of aspartate 
aminotransferase.
GSA-AM was first isolated from the chloroplast stromal fraction of greening barley and 
later from Chlamydomonas and Synechococcus. The enzyme is a dimeric protein 
consisting of two identical subunits of 46 kDa in barley and Synechococcus,44 while in 
Chlamydomonas 45 the active form of the enzyme is 43 kDa.
As in all other aminotransferases, it is generally accepted that PLP is covalently bound 
to a lysine residue as an internal aldimine at the active-site. Purified GSA aminomutase 
is primarily in the pyridoxamine-P form. Both the pyridoxamine-P and pyridoxal-P 
form are able to react with GSA. The resulting intermediates are presumed to be 4,5- 
diaminovaleric acid (DAVA) (28) and 4,5-dioxovaleric acid (31) respectively. A likely 
mechanism proposed by Smith et a l46 is shown in Schemes 1.9a & 1.9b.
t
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The reaction is initiated with GSA and the pyridoxamine-P form of the enzyme (EM), 
resulting in the formation of the C-l aldimine of (S)-GSA (step 1, Scheme 1.9a). 
Abstraction of a methylene hydrogen from the C-4 '-si face of the coenzyme (step 2) 
gives the corresponding quinoid intermediate, which upon proton transfer to C-l is 
converted to the external aldimine of enzyme-bound pyridoxal-P (step 3). This 
intermediate undergoes transaldimination by the amino group of the active site Lys-272 
(step 4a) or by the C-2 amino group of GSA (step 4b), to give (S)-DAVA and the 
pyridoxal co-enzyme form of GSA-AM (EL), or, the corresponding cyclic 
imidazolidine adduct of pyridoxal-P, respectively.
The second half reaction (step 6-9, Scheme 1.9b) is similar except that the chiral centre 
at C-2 rather than the C-l carbonyl of GSA is directly involved in amino group 
transfer, and the steps occur in the reverse order. Prototropic rearrangement (from C-2 
of GSA or C-4 of DAVA to the C-4'-methylene, step 7 and 8) is also from the C-4'-si 
face of the original quinoid intermediate. During this stage of the reaction (step 6-9), 
the C-2 chiral center is directly involved in amino group transfer. C-4 hydrogen DAVA 
is on the C-4 '-re face of the original quinoid intermediate (step 6 ), prototropic 
rearrangement is very unlikely. By analogy with aspartate aminotransferase, proton 
transfer from this side apparently does not occur at appreciable rates.
Pugh et a lA1 on the other hand concluded that only the pyridoxamine form of the 
enzyme is active in catalysing the conversion of glutamate semialdehyde to 
aminolevulinate and that the catalytic mechanism includes enzyme-bound 
diaminovalerate as a central intermediate. Both the groups of Smith and Pugh 
however, agree that the major route for the catalysis takes place through the initial 
combination of the enzyme in its pyridoxamine form (EM) with the aldehyde group of 
the substrate and that the reaction proceeds through interconversion of tautomers (26 
and 29 in Scheme 1.10) of the imine of diaminovalerate with the pyridoxaldimine 
phosphate form of the enzyme (El).
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Scheme 1.10: A possible mechanism for the conversion of of glutamate 1- 
semialdehyde (24) into aminolevulinate (30).
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On the other, both Pugh et al.46 and Smith et a/.47 differ in their opinion of the role and 
activity of EL and in the requirement for release of the intermediate, diaminovalerate. 
Pugh et al. concluded that EL did not contribute significantly to the catalysis of the 
reaction since reduction of EL with NaBH4 produced no detectable loss of enzyme 
activity. Conversely Smith et a l43 concluded that the enzyme has one third of the 
activity of EM. Recently Brody et a/.48 showed that GSA-AM absorption at 338 nm is 
due to pyridoxamine phosphate, while absorption at 418 is due to pyridoxal phosphate 
bound to Lys-272 by a Schiff s base.
1.3.3 Racemization
Amino acid racemases catalyse the interconversation of (S)~ and (R)-amino acids.6 
They allow the deprotonation of the substrate aldimine and subsequent protonation of 
the ketimine to occur from opposite faces of the co-enzyme. Racemases can catalyse 
racemization by using two enzyme-bound bases, one on each face of the co-enzyme 
(Figure 1.1), or one base as depicted in Scheme 1.11. The one-base system requires 
the protein to undergo large changes in conformation so that each face of the co-enzyme 
is accessible. This is known as the 'swinging door1 mechanism 49
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1.3.4 Decarboxylation
Specific decarboxylases are known for more than ten amino acids. In each case the a- 
carboxyl group is cleaved to give CO2 and an amine as the products (Scheme 1.12). 
The N-Ca bond is disposed so that the carboxyl group of (2S)-amino acid is 
perpendicular to the conjugated 7t-electron system, presumably on the 4'-si face of the 
co-enzyme. To date, with the exception of three enzymes, the steric course of all 
reactions of a-amino acid decarboxylases examined from plant, microbial, and 
mammalian sources acting on L-amino acids has been shown to be retentive. These 
include glutamate,50-52 histidine,53’54 tyrosine,55 lysine,56 ornithine,57-58 
arginine,58*59 and methionine decarboxylase 59 The three decarboxylases which show 
alternative stereochemical courses are aminomalonate decarboxylase (an activity of 
serine hydroxy-methyltransferase (SHMT) ) ,60 which produces racemic labelled 
glycine, and wheat61 and batcterial62 a,co-meso-diaminopimelic acid decarboxylases 
which decarboxylate at the (K)-amino acid centre of the substrate to give (2 S)-lysine.
22
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PLP-Iioloenzyme
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Scheme 1.12: A general mechanism for decarboxylation.
1.3.5 Ca -R bond cleavage or formation
The most intensively studied enzyme of this class is serine hydroxymethyltransferase, 
which catalyses the formation of 5,10-methylenetetrahydrofolic acid (33) and glycine 
from tetrahydrofolic acid (32) and (25)-serine by (J-carbon cleavage and is thus a key 
enzyme in single carbon (Ci) metabolism at all oxidation levels (Scheme 1.13). In the 
absence of tetrahydrofolic acid, a slower reaction occurs, giving glycine and 
formaldehyde. SHMT not only catalyses the retro aldol cleavage of a number of 
substrates to give glycine and the appropriate aldehydes63 67 but also decarboxylate
aminomalonic acid68, transaminates (25)-alanine69’71 and catalyse a-hydrogen
/
exchange and aldol condensation with (2S)-amino acids 72 The exceptional range of 
catalytic activity shown by SHMT has stimulated mechanistic investigations into each 
of these reactions.73
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HTT*H 
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Giycine
5,10-methylene tetrahydrofolic acid (33)
Scheme 1.13: The physiological reaction catalysed by SHMT.
1.4 Reactions at the p- and y-Carbon
A large group of PLP-dependent enzymes catalyse nucleophilic displacement of a 
substituent at the P-position of amino acids. These p-replacement reactions involve 
initial cleavage of the Ca-H bond of the PLP-substrate imine to generate a quinoid 
intermediate, followed by elimination from C-P of an anionic group X*, or of HX (after 
protonation of X, thus making it a better leaving group), (Scheme 1.14).74 The
I
resulting amino acrylate intermediates 35 can undergo the reverse reaction sequence, 
Michael addition of X'- and H+ at CP and Ca to generate the PLP-product imine, 
representing the P-replacement reaction. Alternatively, hydrolysis of 35 to pyruvate
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and ammonia constitutes the a , (3-elimination reaction. To date all of these 13- 
replacement and a,p-elimination-deamination reactions have been shown to occur in a 
retentive mode.
Several PLP-dependent enzymes also catalyse p,y-elimination and y-replacement 
reactions.75 Mechanistically, the sequence involves deprotonation at the a  and p 
carbons, followed by elimination of an anionic group Y from CY, to yield the key PLP-
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vinylglycine intermediate (Structure 37, Scheme 1.14). In y-replacement reactions, 
nucleophilic attack by Y' on C7 precedes reprotonation at CP and Ca as in the 
cystathionine y-synthase reaction. Alternatively, protonation at CV generates a PLP-a- 
aminoacronate Schiff base, equivalent to the aminoacrylate intermediate of (3- 
replacement and a , (3-elimination reactions. Substitution can occur at CP by OH 
(threonine synthase ) to give a, p-substituted amino acid or by H+ (7-cystathionase) to 
initiate hydrolysis to a a-ketobutyric acid.
1.5 Suicide inhibitors of PLP dependent enzymes
In general, PLP-dependent enzymes are inhibited by carbonyl-attacking reagents, for 
example, hydroxylamines and hydrazines, and by substrate analogues which cannot 
undergo reaction, but which contain essential active-site binding groups. In the 
absence of the endogeneous co-enzyme, some PLP-dependent enzymes are inhibited by 
the production of PMP in an abortive transaminase side reaction. In inhibitor design, 
some effort has been directed towards the synthesis of substrate analogues containing 
carbonyl-attacking groups, for example, hydrazino acid76 and groups that prevent 
initial deprotonation, for example, Ca-methyl amino acids.77 However, most effort 
has focused upon the design of mechanism-based (kcat) inhibitors.76*80 These type of 
compounds are non reactive until activated by the holoenzyme.
There has been a wide interest in these inhibitors as potential drug candidates, because 
of the pharmacological and therapeutic utility of inhibiting specific PLP enzymes 
(Table 1.3).
Enzymes that require PLP, catalyse some chemical change at the a ,(3 or y-carbon of the 
common a ,[3 or y-amino acids. In every case the role of the PLP moiety is to stabilise
26
Introduction
the carbanionic intermediates that develop during the catalytic process. The suicide 
inhibitors all have latent functional groups that become activated by their proximity to
Table 1.3. Some therapeutically important target enzymes dependent on PLP.
Enzyme Potential effect
bacterial alanine racemase antibacterial
brain GAB A transaminase antiepileptic
mammalian DOPA decarboxylase antihypertensive
mammalian ornithine decarboxylase antineoplastic
the site of an enzyme-generated carbanion. Such an intermediate can break down to 
yield a reactive species that may react with an active site amino acid side chain, or with 
tightly bound PLP co-enzyme. Each of these processes leads to the inactivation of the 
enzyme, in the first case the active site is blocked by an unreactive species and in the 
second case the co-enzyme is no longer available to bind to the substrate. Mechanism 
based inactivating fuctional groups that inhibit PLP enzymes include, acetylinic, 
olefinic, (3-halo substituents and other leaving groups, nitriles, aryl sulphoxides, 
dihydroaromatics and phosphonoamino acids.79
1.5.1 Transaminase Inhibitors
In transamination reactions there are two half reactions for a complete catalytic cycle 
(see Section 1.3.1). In the first half reaction catalysis proceeds through the substrate- 
PLP anion, and this intermediate as well as the product a-imino-PMP enzyme complex
g t
(Scheme 7a) are species allowing for activation of latent functional groups in suicide 
substrates. Activation by net oxidation to the ketoacid equivalent is observed in both 
olefinic and acetylinic amino acid analogues. The olefin analogues include vinyl
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glycine (38),81’82 p-methylene aspartate (39)83 and (E)-methoxy-vinyl glycine (40)84 
and the generally accepted inactivation mechanism is as outlined in Scheme 1.15.
H
NH2
Ena— |sjh2 
H
NQ CH3 
H
< t r c ° 2
Hy t -
' i XN CH3 
H
Enz— NH2
H
N j CH3 
H
Scheme 1.15: Inactivation of aspartate aminotransferase by vinyl glycine.
The acetylenic analogues include the natural product (2S)-propargylglycine,85 and the 
mechanism of inactivation is depicted in Scheme 1.16.
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Some of the more common types of inhibitors contain good leaving groups at CP. 
These compounds are able to undergo facile elimination to generate olefinic 
intermediates. These include, 3-chloro-(2S)-alanine,86’87 an inhibitor of alanine 
aminotransferase, and (25)-serine O-sulfate88 which inhibits aspartate aminotransferase 
and glutamate decarboxylase.
The accepted mechanism had been that the 'killing' species was the aminoacryl-PLP 
intermediate, which undergoes a putative Michael reaction with an enzyme bound
f
nucleophile. Although this is the case with some enzymes, such as serine hydroxy 
methyl-transferase (SHMT), Metzler and co-worker89 have shown that the inactivation 
of aspartate p-decarboxylase is not due to the occurrence of a Michael reaction. Bright
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and co-workers have used the nitro group of 3-nitro alanine as an inactivator of 
aspartate aminotransferase and alanine aminotransferase.90 The nitro alanine undergoes 
a-proton abstraction followed by (J-nitro elimination. Alanine aminotransferase is also 
inhibited by cycloserine,91 while aspartate aminotransferase is inhibited to varying 
extents by a  and y-cycloglutamic acids92-94 (Scheme 1.17). a-Cycloglutamic acids is 
believed to acylate an active site bound nucleophile to give a stable inactivated 
complex, whilst y-cycloglutamate is thought to form an oxime of (3-aminooxyglutamate 
with PLP by ring opening of the isoxazolidine ring.
Various analogues of GAB A inhibit GABA-transaminase. These include p-chloro-, 3-
f
phenyl, y-acetylenic and y-vinyl GABA as well as ethanolamine O -sulfate.95 
Mammalian GABA-transaminase is inhibited by the naturally occurring product
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gabaculine (41) via an interesting aromatisation mechanism to give the conjugated PMP 
adduct (Scheme 1.18, (42))96-97
PLP dependent racemase enzymes are important because they are involved in the 
biosynthetic pathway leading to peptidoglycan. Many suicide substrates are known for 
the racemases, including (3-substituted alanines for alanine racemase98"100 and 
phosphoalanine (for gram positive alanine racemase only) . 101' 102 Phosphoalanine is 
thought to inhibit alanine racemase via an initial reversible formation of a weak complex 
which slowly isomerises to a stoichiometric complex that dissociates extremely slowly. 
The complex is not reducible with borohydride.103
1.5.2 Other PLP Inhibitors
Decarboxylase inhibitors are particularly important because of the role these enzymes 
play in the biosynthesis of many pharmocologically active amines (see p. 23). Many 
examples with alkyne, olfenic, and mon-, di or trihalomethyl groups have been 
reported. Since decarboxylases do not abstract the substrate a-hydrogen they can 
decarboxylate a-methyl amino acids. Thus a-ethynyl, a-vinyl, a-fluoromethyl, and
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a,a-difluoromethyl amino acids serve as sucicde substrates. For example, the 
inactivation of DOPA decarboxylase by a-vinyl DOPA104 105 (43) and of ornithine 
decarboxylase by a,a-difluoromethylomithine106 (44) are shown below:
Scheme 1.19: Inactivation of DOPA decarboxylase by a-vinyl DOPA (43) and of 
ornithine decarboxylase by a,a-difluoromethylornithine (44).
5-Hexyne-1,4-diamine inactivates omithin^ decarboxylase, 107 presumably via similar 
mechanism to that described for a-vinyl DOPA. Other inhibitors of ornithine 
decarboxlyase include p, y-dehydroornithine, 108 a-fluoromethyl putrescine109 and 
a,a-difluoromethyl ornithine. 107 Halomethyl and olefinic groups have been
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incorporated into a single molecule by Bey and collegues . 1 10 
a-Fluoromethyldehydroomithine and a,a-fluromethyldehydroputrescine have been 
tested as ornithine inhibitors. The dehyroomithine is a more effective inhibitor than the 
saturated analogue and its Kj is 30 times lower.
Enzymes which catalyse a,(J-elimination occasionally undergo an abortive reaction 
with a physiological substrate. For example, threonine deaminase is very slowly 
inactivated by (25)-serine approximately once every 104 turnovers, 111 note that a 
similar situation occurs with 3-chloroalanine. 112 In contrast, (2S,3/?)-threonine does 
not cause inactivation, presumably as the intermediate formed is less susceptible to 
Michael addition or enamine condensation to give the Schnackerz type product (45) 
(Scheme 1.20) .113
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Scheme 1.20: Two possible mechanisms for the inactivation of enzymes that 
catalyse a,fi—elimination reactions. Route a causes the modified coenzyme to be 
covalently bound to the enzyme, and route b leads to the Schnackerz adduct (45).
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E. coli tryptophanase is irreversibly inhibited by trifluoroalanine.114 It is proposed that 
the difluoroaminoacrylyl-PLP-aldimine complex is more susceptible to nucleophilic 
attack at C-3 by an enzyme bound base, than to hydrolysis at the aldimine carbon atom. 
The enzyme p-cystathionase is irreversibly inactivated by the fungal toxin rhizobiotoxin 
(Scheme 1.21 (46)).115 The alkoxyvinylglycine analogue rhizobiotoxin may undergo 
initial Ca-H abstraction, and then an addition and elimination sequence, similar to that 
for (£T)-metlioxyvinylglycine (40) with aspartate aminotransferase.
NH2 nh2
OH
h2n ^ J
(46)
+  2 )  - H
PLP
1 ) p-cystathionase
ii Hpo lT°
^ n ^ c h 3
H
NH2
Enz- Nu
C02’
Inactivated
enzyme
Scheme 1.21: The inactivation of p-cystathionase by rhizobiotoxin (46).
p-Cystathionase is also irreversibly inhibited by trifluoroalanine, and tryptophan 
synthase is subject to suicide inhibition by trifluoro-, trichloro- and dichloroalanine.116 
E. coli tryptophan synthase also reacts with cyanoglycine, causing inhibition which is
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reversible upon dialysis or gel-filtration. The inactivated coenzyme is presumed to be a 
stable P-imine PLP adduct (47) .117
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RESULTS AND DISCUSSION
Results and Discussion
2.0 Results and Discussion
2.1 Synthesis of aspartic acid methyl ester and amide derivatives
J. Kovacs et alns have reported on the formation of a-methyl aspartate ester (50) 
from five membered ring aspartic anhydride hydrobromide (49) (Scheme 2.1). Due to 
the strong inductive effect of the protonated amino group, the anhydride ring was 
opened predominantly in the a-position. An excess of silver oxide was needed to 
remove the bromide ion.119 Electrophoretic120 and chromatographic analysis of the 
mixture of asparagine and isoasparagine (obtained from the reaction of the crude ester 
with ammonia) indicated that the a-methyl ester was obtained in 95% yield.
* '♦  H
c o 2h _ J U  H^ 7 - i  — SiiU h - ^ c o *h 
° o ^ °  h3c o 2c
(48) (49) (50)
; Reagents and conditions: (i) Ac20; then AcOH/HBr, (ii) CH3OH 
Scheme 2.1: Kovacs's synthesis of a-methyl aspartic acid.
In the absence of the inductive effect, the nucleophilic attack is nearly equally 
distributed between the a  -and p- carboxyl groups as in the polymerization of the free 
aspartic anhydride to a,p-poly-L-aspartic acid.119 Aspartic anhydride hydrobromide 
(49) was prepared directly from carbobenzoxy-(2S) or (2R) aspartic acid by 
successive treatment with acetic anhydride and dry hydrogen bromide. Gani et al.121 
reported the formation of a-methyl ester via ring opening of the cyclic trifluoroacetyl
t
aspartic anhydride (51) with methanol as 80% of the total mixture. In view of this 
low selectivity and difficulty encountered with the purification, we decided to
H
CBz-N
H
HO2C
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develop a new synthetic route for the preparation of the a-methyl ester of (2S)- 
aspartic acid.
Following the method of Baldwin et al.,122 (2S)-aspartic acid (52) was reacted with 
allyl alcohol in the presence of acetyl chloride to give (3-allyl aspartic acid ester 
hydrochloride salt (53) in 70% yield (Scheme 2.2). Benzyl carbamate protection of 
the a-amino group followed by esterification using ethereal diazomethane gave the 
fully protected aspartate (55) in 6 8 % yield. Deprotection of the allyl group with 
palladium (Pd°) followed by catalytic hydrogenolysis of the benzyloxy group gave 
the required a-methyl aspartate ester (57) in 87% yield, m.p. 169-71 °C (lit. ,119 167 
°C); [a]D 38.40 (c 0.5, H2Q) {lit. ,119 [a]D28 +37.60 (c 0.5, H20 ) } .
(51)
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h2n c o 2h 
 .
ho2c
(52)
(0 M .
o  o
PhCH20-C-NH C-i 
H02C
(54)
O O 
PhCH20 -  C- NH C -0
H3CO2C
(55)
(IV)
PhCH20-C-NH C02H m H2N C02H
H-4— ^ , H*«>— /
h3co2c h3c o 2c
(56) (57)
Reagents and conditions : (i) allyl alcohol, acetyl chloride, 18 h, r.t., 70%;
(ii) PhCH2OCOCl, K2C03, 6 h, r.t., 79%; (iii) CH2N2, Et20, 2 h, r.t., 68%;
(iv) Pd (PPh3)4, PPh3, Pyrrolidine, CH2Q 2, 1 h, r.t., 53%; (v) H2, Pd/C, CH3OH, 
12 h, r.t., 87%.
Scheme 2 .2 : Synthesis of the a-methyl ester of aspartic acid.
(25)-Aspartic acid P-methyl ester hydrochloride (58) was prepared from (25)-aspartic 
acid (52) and methanol following the method of Goodman and Boardman123 in 80% 
yield. The m.p. of (58) was 189-90 °C, which was quite different from that quoted by 
Goodman and Boardman (m.p. 204 °C). However, Schwarz, et al.,124 had reported a 
m.p. of 191-193 °C, which was in close agreement to our value. Refluxing the 
hydrochloride salt with propylene oxide gave the (25)-aspartic acid P-methyl ester 
(59) in 90% yield, m.p. 190 °C (lit ,125 194-195 °C), (Scheme 2.3).
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Cl- +
H4 _ V C02H _ iL  Hh3^ C° 2CH3 " f \  /CO*CH3
H02C H02C ho2c
(52) (58) ' (59)
Reagents and conditions: (i) SOCl2> CH3OH, -10 °C; then r.t., 30 min, 80%; 
(ii) Propyleneoxide, CH3CH2OH, 3 h, 80 °C, 90%;
Scheme 2.3: Synthesis of the ft-methyl ester of aspartic acid.
(25)-Aspartic acid a,p-dimethylester (60) was prepared by the acid-catalysed 
esterification of (25)--aspartic acid in methanol acccording to tlie method of Gmeiner 
et al125 to give the hydrochloride salt in 80% yield, m.p. 100-101 °C (lit. ,125 114­
15 °C). Treatment of the dimethyl ester with a concentrated solution of ammonia in 
methanol for 45 h gave the a,(3-diamide (61) in near quantitative yield, m.p. 214 °C 
(decomp.); [a]D +8.25 (c 0.4, water), (Scheme 2.4).
Cl- +
HgN C02H (|) H3N C02CH3 (I) H2N CONH2
— '  — 1L*. H4 — /    L ...^  H-^— /
ho2c  h3c o 2c  H2NOC
(52) (60) (61)
Reagents and conditions: (i) SOQ2, CH3OH, 4 5 h, rt, 80%; (ii) NH3, CH3OH, 
45 h, rt, 98%.
Scheme 2.4: Synthesis of(2S)-Aspartic acid a,p-diamide.
In order to synthesise the a-monoamide of (25)-aspartic acid it was decided to utilise 
the p-allyl ester of N-benzyloxycarbonyl aspartic acid (54) as the starting material. 
Formation of the isobutyl carbonic mixed anhydride followed by treatment with 
ammonia gave the protected a-amide (62), m.p. 86  °C; mlz (Found: M+, 306.1208.
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C15H18N2O5 requires 306.1215), (Scheme 2.5). The use of excess ammonia in this 
reaction resulted in a side reaction. The a-amide was deprotected by treatment with 
palladium (Pd°) and subsequent catalytic hydrogenation using Pd/C effected the 
removal of the allyl and the benzyl groups, respectively, to yield the a-monoamide
(64) in 75% yield, m.p. 214-216 °C (decomp.) {lit. ,118 m.p. 212-214 °C (decomp.)}; 
[<x]D +16.7 (c 1.8, 0.1 mol dm-3 HC1) {lit. ,118 [<x]D26 +15.4 (c 1.8, 0.1 mol dm-3 
HC1)}.
O
PhCH20-C~NH
■ f
H02C
(54)
(i)
O O 
PhCH20-C~NH C-
— f
H2NOC
(62)
(ii)
P
PhCH20-C-N H  C02H 
— f
H2NOC
(63)
h2n co2h 
H"4 11 f  
h2noc
(64)
Reagents and conditions: (i) NMM, IBCF, THF, -10 °C; then NH3, CH3OH, 15 h, 
rt, 62%; (ii) Pd(PPh3>4, PPh3, Pyrrolidine, CH2CI2, 10 min, rt, 66%; (iii) H2, Pd/C, 
CH3OH, 16 h, rt, 75%.
Scheme 2.5: Synthesis of isoasparagine.
The pH dependence of the 13C chemical shift of the a- and P-carbons of aspartate and 
some of its analogues substituted at the a- and/or p-carboxylate were monitored to 
determine experimentally pKa changes expected as a result of neutralization of the 
carboxylates. Table 2.1* provides the summary of the analogues for which pKa's 
were measured, with aspartate serving as a reference.
* These pKa values were determined by Profs. Klaus Schnackerz and Paul Cook of 
the Deparment of Biochemistry and Molecular Biology, University of North Texas 
Health Science Center.
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Table 2.1: Experimentally Determined a-Amine pKa valuesa and Calculated Proton
Ajfinitiesb for Aspartate Analogues
Compound pKa Proton Affinity (KJ/mol)
(25)-Aspartate 
a,(3carboxylates unprotonated 9.82 (a), 9.84 (b) -1657.53
p-carboxylate unprotonated ND 1238.25
a-carboxylate unprotonated ND -1284.28
a,p-carboxylates protonated ND -876.77
Methylesters
a-monomethylester 7.84 (a), 7.4 (b) -1251.31
P-monomethylester 8.72 (a), 8.73 (b) -1295.28
a,P-dimethylester 6.70 (a), 6.70 (b) -897.13
Carboxyl amides
a-monoamide 7.97 (a), 7.99 (b) -1255.49
p-monoamide 0.67 (a), 9.64 (b) -l20fc.63
a,p-diamide 7.02 (a), 6.99 (b) -027.59
Carboxyl-guanidinium H- 
bondsc
a-guanidinium complex ND 1319.25
P-guanidinium complex ND 1319.63
a,p-bisguanidinium complex ND 1145.37
Carboxyl-guanidinium H 
bondsc
a-guanidinium complex ND -1392.18
p-guanidinium complex ND 1394.53
a,p-bisguanidinium complex ND -1144.05
apKa values are estimated from the pH dependence of the 13C chemical shift of the a- and 13-
carbons of (2S)-aspartate and its analogs. 
bProton affinities were calculated as stated in the text.
cProton affinities were calculated for a system in which two hydrogen-bonds are formed 
between guanidinium and the carboxylate of interest, with either free optimization or a 
constrained planar complex (see K. Khayer et. al., Bioorg. Med. Chem. Lett., 1996,6, in 
the press).
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Modification of the a-carboxylate either by esterification or amidation results in a 
decrease in the a-amine pKa by about 1.8-2 pH units, modification of the P- 
carboxylate results in about a 0.8-1 pH unit decreases in the pKa, while modification 
of both carboxylates is additive, giving a decrease of 2.8-3 pH units. Calculated 
proton affinities for the above analogues show changes that roughly parallel the 
changes in pKa values. Whether neutralization of the a-carboxyl is by protonation, 
esterification or amidation, a decrease in the free energy by 400-418 kJ/mol is 
observed, while in the case where both are neutralized, the change is 741-787 kJ/mol, 
suggesting that a change of 200-250 kJ/mol should be obtained for each pH unit 
change in the pKa of the a-amine. Estimated changes of 360-375 kJ/mol for 
neutralization of the p-carboxyl are higher than the expected 200-250 kJ/mol, and this 
likely reflects restricting the P-carboxyl from hydrogen-bonding with the a-amine.
Comparing the Michaelis complex of aspartate aminotransferase with aspartate, 
complexes in which guanidinium is hydrogen-bonded with the carboxylates were also 
modeled with free optimization and with a constrained geometry with the latter likely 
more accurately reflecting the Michaelis complex. The changes in the case of the 
guanidinium complexes are much smaller than those observed for any of the aspartate 
analogues or for aspartate protonated at its carboxylates. The smaller changes suggest 
less than complete charge neutralization. Even with both carboxylates complexed 
with guanidinium, data suggest a change of >2 but <3 pH units in the pKa of the a- 
amine. Figure 1* shows the (2S)-aspartate Michaelis complex model used with the a- 
amine of the amino acid either protonated or unprotonated. Hydrogen-bonding 
distances from the a-carboxylate to the guanidinium of Arg-386 are 2 .7 7  A and 2 .9 3  
A, while those from the P-carboxyl to Arg-292 are 2.81 A and 3.29 A. The distances
t
^Molecular modelling carried out by Dr. J. Wilkie in the School of Chemistry, 
University of St Andrews.
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Asn 194
Am Sftfi
Aspartate
Arg 292
Figure 2.1. Model of the L-Aspartate Michaelis Complex of Aspartate 
Aminotransferase. The superposition of two complexes is shown in which the 
a-amine of L-aspartate is protonated (above) or unprotonated (below). The 
guanidinium of arginine 386 is shown at the top of the figure, while that of arginine 
292 is at the bottom.
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change slightly upon deprotonation of the a-amine, for the a-carboxyl/Arg~386 to 
2.77 A and 2.70 A, and for the (3 -carboxyl/Arg-292 to 2.75 A and 3.27 A, 
respectively.
The proton affinity of the a-amine of aspartate in Michaelis complex with aspartate 
aminotransferase, is calculated as -1320.84 kJ/mol. The difference of 334.72 kJ/mol 
between the latter and the proton affinity of aspartate with both carboxylates ionized 
suggests a decrease in the pKa of the a-amine of aspartate by >1 and <2 pH units 
upon binding of aspartate to the pyridoxamine form of aspartate aminotransferase.31 
Thus, although both of the carboxylates of aspartate form hydrogen-bonds to Arg-292 
and Arg-386 upon binding to enzyme, charge is not completely neutralized at either 
of the two.
a-Substituted P-Carboxylates. The geometry of L-aspartate is such that the p- 
carboxylate is well placed to accept a hydrogen-bond from the protonated a-amine. 
Neutralization of the p-carboxylate (by a counter-ion such as guanidinium, or by 
esterification, etc.) abolishes, or severely curtails, hydrogen-bonding tendency, while 
in the case of fully ionised aspartate, the zwitterionic species is stable. However, in 
the case of neutralization of the a-carboxylate alone, the proton affinity of the amine 
is lowered, relative to the p-carboxylate, sufficiently to abolish the zwitterionic 
minimum, and this results in the spontaneous transfer of a proton from the amine to 
the p-carboxylate during the course of optimisation. To determine the effect of 
neutralization of the a-carboxylate alone on amine proton affinity, amine N-H bonds 
were fixed at 1.028 A in the protonated form. The Michaelis Complex of aspartate 
aminotransferase with L-aspartate was derived from the external aldimine of aspartate 
aminotransferase with aspartate126 as obtained from the Brookhaven protein data baseI
as follows.
Results and Discussion
(1) The correct bonding for the Michaelis complex was established, i.e. Lys-258 was 
reattached via Schiff base linkage to the active site PLP, but the external aldimine 
coordinates were retained.
(2) MM (AMBER) optimisation of the whole protein was carried out to obtain the 
correct co-ordinates for the Michaelis complex.
(3) Excess protein was deleted leaving only model system including the bound 
aspartate, PLP, the two guanidinium groups of arginines 386 and 292 that form a 
double hydrogen-bond with the carboxylates of aspartate, along with Try-140 and 
Asn-194 which are in close proximity to the bound aspartate, Figure 2.1.
(4) The coordinates of the remaining (those listed in 3 above) protein atoms were 
fixed, and the position and internal geometry of the bound aspartate was optimised.
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2.2. Synthesis of 2,3-diaminopropan-l-ol hydrogensulfate ester
Glutamate 1-semialdehyde aminomutase, as mentioned earlier (Chapter 1, p 16) is an 
exceptional enzyme in that, although it is classified as a mutase, it actually functions 
as an aminotransferase (transferring amino and oxo functions within the molecule).
In order to shed more light on the mechanism of this enzyme, it is important for us to 
design and synthesis substrates and inhibitors. One such substrate/inbibitor would be
2,3-diaminopropan-l-ol hydrogen sulfate ester (74). Although this compound has 
not been reported in the literature, it's possible precursor, 2,3-diamino-1-propanol127 
has attracted more attention due to its involvement in antitumor activity. Platinum
(II) complexes of 2,3-diamino propanol (pnOH) isomers shows antitumor activities 
against leukemia L1210.128 Among the Pt (II) complexes containing pnOH isomers, 
R-pnOH showed higher antitumor activity than those containing S~ or racemic pnOH.
There are very few syntheses in the literature for the preparation of 2,3- 
diaminopropan-l-ol. Okamoto et al.127 have prepared 2,3-diaminopropan-l-ol (6 6 ) 
by reaction of the tetrahydropyran derivative of 2,3-dibromopropan-l-ol (65) with 
sodium azide in DMSO followed by reduction with LiAlHU in THF or with H2S in 
methanol (Scheme 2.6). Resolution of the racemic 2,3-diaminopropanol was 
achieved by a modification of the method used in the case of 1,2 -propane diamine. 128 
The dihydrochloride of 2,3-diaminopropanol was then converted into the free form by 
passing the salt through a column of AmberliteIRA-410 resin.
/
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CH2-CH-CH2Br + 
Br
2N3
(65)
DMSO
a CH2-CH-CH2N3 H2S, CH3OH/ or OH-CH2-CH-CH2NH2
I
l  r i A m ,
NH2 
(66)
N3 UAIH4 , H+
Scheme 2.6: Preparation of 2,3-diaminopropan-l-ol.
Considering the potent antitumor activity and the need to unravel the mechanism of 
glutamate 1-semialdehyde it was important for us to develop a new synthetic route to
2 ,3 -diaminopropan- 1 -ol.
Benzyloxycarbonyl protection of (25')-asparagine (67) using Schotten-Baumann 
conditions gave (6 8 ) in 78% yield, m.p. 160-62 °C (decomp.) {lit. ,137 165 °C 
(decomp.)}; [a]D +6.4 (c 1.6, AcOH) {lit. ,137 [a]D +7.8 (c 1.6, AcOH)}, 
(Scheme 2.7).
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O O
NH2 C“ NH2 nv CBZ-NH C~NH2
/  H-4— /
HC^C H02C
(67) (68)
H
CBZ-NH NH2 . . . . . CBZ-NH N-CBZ %
H - i- V  M  ^  H 4 — /  Qv)
H02C ho2c
(69) (70)
H
CBZ-NH N-CBZ NH2 NH2
H*«j)— /   (v) ^ (vi)
HOH2C hoh2c
(71) (66)
►
nh2 nh2
H-»>—V
ho3so h2c  *2HCI
(74)
Reagents and conditions: (i) PhCH2OCOCl, NaHC0 3 , H20 ; (ii) PIFA, DMF/H2O, r.t.;
(iii) PhCH2OCOCl, NaHC03, H20 , r.t.; (iv) IBCF, NMM, THF, -25 °C; then NaBH4, 
THF, -25 °C; (v) H2, Pd/C, MeOH; (vi) CISO3H, DCM, r.t., 45 h.
Scheme 2.7: Synthesis of2,3-diaminopropyl hydrogensulfate.
The amide was then converted into the amine (69) (m.p. 230-232 °C {lit. , 129 m.p. 
228-230 °C (decomp.)}; [afo -6.9 (c 0.4, Fmol dnr3 NaOH) {lit ,129 [ot]D -7.8 (c 0.4, 
1 mol dm-3 NaOH)}) using the conditions of Waki, 129 phenyl iodosyl bis 
(trifluoroacetate) (PIFA) in a mixture of DMF and water. Subsequent protection of
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the free amino group using again benzylchloroformate gave the bis-Cbz protected 
diamine (70) in 92% yield. Reduction of 70, was first tried with borane (3 equivalent) 
in THF, however even after 16 h reflux the peaks at 8  8.17 and 8  173.84 in the *H- 
and 13C-NMR spectrum were still present. Using 5 equivalences of borane and 
refluxing the mixture for 4 h showed the appearance of a new spot on the TLC plate.
The XH-NMR spectrum of the crude mixture was quite complex and it was difficult to 
access whether or not some reduction had occured. However the 13C-NMR spectrum 
was more promising and showed an additional peak for the alcoholic CH2 at 
8  62.1 ppm. Refluxing the reaction for 2 days did improve the ratio of product to 
starting material. However, due to the problems with the extraction and purification 
of this product, we decided to pursue alternative methods. Reduction using LLAIH4  
(1 .2  equivalent) at 0 °C was also unsuccessful probably due to the formation of the 
lithium salt of the acid. In order to overcome this problem, the methyl ester (75) of
(70) was prepared and subjected to the same reduction conditions. Although the 
13C-NMR was again encouraging, problems with purification (by column 
chromatography) and extraction led us to abandon this strategy. The a-acid was 
however, successfully transformed into alcohol (71) by reduction of the preformed 
&/s(N2’3-benzyloxycarbonyl)-propan isobutylcarbonic anhydride with NaBH4 at 
-30 °C, but in a moderate 6 8 % yield. 13C-NMR spectrum showed the complete 
disappearance of the acid carbonyl peak (at 8  173.84) and an additional peak at 8  62.1 
corresponding to the alcohol (71) {m.p. 96-97 °C; mlz (Found: [M + H]+, 373.1387. 
Ci9H21N20 6 requires 373.1399)}.
Sulfation of the diamino protected alcohol (71) with chlorosulfonic acid in 
trifluoroacetic acid following the method of Previero130 was unsuccessful. Although,
t
reaction with chloro sulfonic acid in DCM gave a white solid of m.p. 145-150°C 
(slow), the mass spectrum showed the compound had a molecular weight of 486,
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which was not consistent with the desired product (72). Due to its insolubility and 
rapid decomposition we were unable to characterise this compound.
CBZ-NH H 
N-CBZ 
ho3s o h 2c
(72)
In an attempt to aid the sulfation reaction we decided to introduce the sulfate after the 
removal of the amino protecting group from the alcohol. Removal of the 
benzyloxycarbonyl protecting groups by catalytic hydrogenation using palladium on 
activated carbon gave the free diamino alcohol (6 6 ) in 93% yield. This was then 
converted into the dihydrochloride salt (73) for full characterisation purposes, m.p. 
180-81 °C (lit. ,127 172-74 °C). The 13C-NMR spectrum possessed only three peaks, 
at 8 61.98, 52.87 and 41.36, consistent with the alcoholic CH2, a-CH and P-CH2 
carbons respectively.
Attempted sulfation of the diamino alcohol (6 6 ) using the method of Previero130 was 
again unsuccessful. However, reaction with chlorosulfonic acid in dichloromethane 
gave the desired compound (74) as a hydrochloride salt. The 13C-NMR spectrum 
showed the partial disappearance of the alcoholic peak and the presence of a new 
peak at 5 67.44, indicates the formation the sulfated product. Attempted purification 
of the crude material by ion-exchange column chromatography using strong and weak 
cation exchangers met with failure. However recrystallisation from water/ ethanol 
gave white solid, m.p. 55-60 °C, which was > 80% pure as judged by NMR 
spectroscopy.
/ 1
51
Results and Discussion
2.2.1 Future Work
We have developed a successful route to 2,3-diamino propyl hydrogensulfate starting 
from (2S)-asparagine, although the final compound obtained was not pure 
spectroscopically.* In order to improve the yield and purity of our target, a possible 
adaptation of the synthesis of Waki et al.129 could be considered. They have 
sucessfully converted N2-benzyloxycarbonyl-(2S)-2,3-diaminopropanoic acid into 
(2S)-2,3-diamino propanoic acid hydrocloride in 93% yield. Reduction of this 
propanoic acid with NaBH* and subsequent sulfation of that amino alcohol with 
chlorosulfonic acid would give the desired sulfated product (Scheme 2.8).
(74)
Reagents and conditions: (i) CH3CO2H/ H2O, Pd/C; then 1 mol dm' 3 HC1;
(ii) NaBH* THF, -25 °C; (iii) CISO3H, DCM, r.t., 45 h.
Scheme 2.8 : A possible synthesis of 2,3-diamino propyl hydrogen sulfate.
*This compound has purified by ion-exchange chromatography and was used in 
kinetic studies in the laboratory of Prof. Robert John.
CBZ- NH NH2 
— /
ho2c
(69)
HQ2u
hoh2c
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2.3 Synthesis of 3-[2H]-serine
The amino acid (25)-serine is involved in many biological reactions in which 
substitution or elimination occurs at C-3.131 The availability of (25)-serine, chirally 
labelled at C-3 with isotopic hydrogen would allow the stereochemical course of 
some of these reactions to be assessed. Although several synthesis of (2S)-serine 
stereospecifically labelled at C-3 with tritium132 or deuterium121-132c> 133 have been 
reported in the literature, they are either very low yielding or the amount of 
incorporation of 3H or 2H is insufficient to carry out any meaningful studies. Gani 
and Young, however have successfully synthesised C-3 chirally deuterated-(25)- 
serine in 8.5% yield with >95% incorporation of deuterium. 121 The key reaction in 
their sequence was a Baeyer-Villiger rearrangement at a primary migrating centre. 
We decided to follow this protocol in a hope of improving the yield of the Baeyer- 
Villiger reaction (lowest yielding step in the synthesis, 20%) so as to obtain a better 
overall yield.
The synthesis of unlabelled serine was first pursued, in order to investigate the 
rearrangement further. (25)-Aspartic acid (52) was treated with trifluoroacetic 
anhydride and the intermediate anhydride was treated with methanol in situ, 
following the method of Weygand.134 The ^-NM R spectrum of the crude product 
showed that two methyl esters , (76), (R1 = Me, R2 = H) and (R!= H, R2 = Me) were 
present in the ratio 4:1 as judged by integration of the methoxy singlets at 3.79 and 
3.71 ppm respectively (Scheme 2.9).
/
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(77) R1 «CH(CH3)2, R2 «H  
(93) R1*C H 2CCI3,R2 «H  
(95)R1*CH2CH=CH2iR2»H
o
F3COCNH c -  Cl 
R1 O2C
(78) R1«CH(CH3)2 
(97) R1-  CH2CH=CH2
(iv)
0
F3COCNH c -  chn2 
-—/
R1 0 2C
(79) R1 -  CH(CH3)2 
(98) R1 *  CH2CH=CH2
(V)
O
F3COCNH C- CH3 
H-.X—/
R1 02C
(vi)
F3COCNH OCORJ 
H-.^—J  
r 1o 2c
(vii)
(80) R1 « iPr
(81) R1 = Et
(82) R1 = CH3 
(99) R1 = allyl
(83) R1 « CH3, R3 = C H 3
(84) R1 = CH3, R3 = CF3
(85) R1 *  CH3, R3 = OC H3
(86) R1 .  IPr, R3 » C H3
NH2 OH 
W .X -J
ho2c
(87)
Reagents and conditions: (i) TFAA, THF, 0 °C; (ii) isopropanol, reflux at 40 °C;
(iii) SOCI2, DCM; (iv) CH2N2, THF, ether, 0 °C; then reflux, 2 h; (v) Excess aq. HI, 
1 h; (vi) 27% H2O2, TFAA, DCM, 0 °C; then reflux, 45 h; (vii) 6  M HC1, reflux, 2 h.
Scheme 2.9: Synthesis of serine.
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In an attempt to improve this selectivity, we have decided to use isopropanol as the 
solvent. The reaction was found to be stereospecific since only one set of signals for 
the isopropyl group were seen in the ^-NM R spectrum, at 1.27 ppm for the methyl 
protons and at 5.11 ppm for the isopropyl C-2 proton. Extra bulk of the isopropanol 
makes it more selective nucleophile and sucesptible to attack at the more reactive 
a-carbonyl carbon of cyclic trifluoroacetic anhydride (51). The a-isopropyl-W- 
trifluoroacetyl-(3-aspartic acid ester (77) was then refluxed with excess thionyl 
chloride. This was found not to be a reliable method for the formation of the acid 
chloride, due to the reformation of cyclic anhydride. However, refluxing in 
dichloromethane using 4 equivalents of thionyl chloride gave the required acid 
chloride (78) in 75% yield, m.p. 120-123 °C (lit.,138 1 23-5 °C); [a]D +65.4 (c 0.63, 
CH2C12) {lit. , 138 [a]D +65.8 (c 0.63, CH2C12)}. Reaction with freshly prepared 
alcohol free and moisture free excess ethereal diazomethane then gave the desired 
diazoketone (79) in 95% yield after recrystallisation from diethyl ether/ cyclohexane. 
The compound showed an absorbance at 2126 cm 1 in the infra-red, and exhibited a 
singlet at 5.32 in the ^-NM R spectrum, (m.p. 91-93 °C; mlz (Found: [M + H]+ 
296.0856. C10H13N3O4F3 requires 296.0858). Treatment of the diazoketone with an 
excess of aqueous hydriodic acid in methylene chloride then gave the methyl ketone 
(80) in 78% yield, (Found: C, 44.45; H, 5.3; N, 5.22. C10H15NO4F3 requires C, 44.6; 
H, 5.25; N, 5.2%). The XH-NMR spectrum showed a methyl ketone signal at 2.18 
ppm and the disappearance of the diazoketone signal at 5.32 ppm.
Having obtained the desired a-isopropyl methyl ketone (80), we were unable to 
induce this to undergo Baeyer-Villiger oxidation under a wide variety of conditions. 
As 90% hydrogen peroxide, for making trifluroroperoxyacetic acid (the grade used by 
Gani and Young) was also no longer commercially availability, we used three times 
as much 27% H20 2 for making trifluoroperoxyacetic acid. The Baeyer-Villiger 
oxidation was attempted using different reaction times, temperature, solvent and neat 
(without solvent), and in each case no peaks corresponding to the product in the
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^-N M R  spectrum could be observed. Even when the oxidation was carried out 
using alternative peracids; peroxyacetic acid and peroxymalic acid (from 27% H20 2) 
no reaction occured. It, therefore appears, that although the isopropyl group enhances 
regioselectivity in the opening of the cyclic anhydride (51), the Baeyer-Villiger 
reaction under a variety of conditions is unsuccessful for the ethyl (81, R1=Et) and 
isopropyl esters (80, R1=CH(CH3)2). This is quite different from the results reported 
by Gani and Young, who, in the case of the methyl ester (82, R1=CH3) observed three 
compounds; the desired acetate (83, R1*CH3>R2=GH3), the transesterification product 
(84, R1=CH3, R2=CF3) and the diester (85, R^CH^ R2=OCH3) as a result of methyl 
migration which was an unexpecting result.121
The failure of this Baeyer-Villiger oxidation leads us to pursue an alternative route to 
the desired acetate (86). We decided to try and make use of the a-peracid (89) in a 
hope that we may get intramolecular ring closure to form the Criegee intermediate, 
with subsequently breakdown of the cyclic intermediate to give the desired acetate 
ester (Scheme 2.10).
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Scheme 2.10: An alternate method for the preparation of acetate by Baeyer Villiger
oxidation.
The synthesis of the free a-acid by simple hydrolysis of the ester (80) proved more 
difficult than expected, as the trifluroacetyl group was very base labile. Attempted 
hydrolysis of a-isopropyl methyl ketone with NaOH/CH^OH led to hydrolysis of 
both the trifluoroacetyl and isopropyl groups (92). Disappearance of the isopropyl 
peaks at 8  1.23 & 5.05 and at 8  21.49 and 70.43 in the *H-NMR and 13C-NMR 
spectrum respectively indicated removal of isopropyl group. A new peak at 8  173.45 
in the latter spectrum was also indicative of the presence of a free carboxylic acid. 
The TLC of this reaction product also showed a positive ninhydrin test.
Since we were unable to hydrolyse the a-isopropyl group without affecting the 
trifluoroacetyl group, we decided to replace the a-ester with a more labile group, that 
could be removed in the presence of the trifluoroacetyl group.
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In the literature, the 2 ,2 ,2 -trichloroethyl group has been found to be very labile upon 
treatment with Zn/acetic acid.135 We reasoned that the trifluoroacetyl group would be 
unaffected by these condition. Treatment of the cyclic anhydride (51) with neat 
trichloroethanol at r.t. for 45 h gave the trichloroethyl ester (93) in only 50% yield. 
iH-NMR spectrum of the crude product in C2HC13 showed peaks at 5 4.82 (m) and 8  
8.17 (br) indicating the presence of -OCH2CCl3 and -C02H group (exchangeable with 
D20). Addition of etheareal diazomethane to this reaction mixture resulted in two 
methoxy singlet at 8  3.71 and 8  3.80 (the ratio of a- and p-methyl ester is 1:2) which 
indicating that the opening of the cyclic anhydride with trichloroethanol was not 
regioselective.
Refluxing the cyclic anhydride with 3 equivalents of trichloroethanol in THF under 
N2 for 7 days caused extensive decomposition. An improved yield (90% before 
purification) was obtained when the cyclic anhydride was treated with excess 
trichloroethanol and then stirred vigorously at 40 °C under N2 overnight. But when 
the a-trichloroethyl ester-P-acid was subjected to reaction with thionyl chloride no 
reaction occurred. The 300 MHz iH-NMR spectrum showed no C 02H peak, 
however, additional peaks at 8  3.04-3.38 (2 H, m, p-CH2), 8  4.98 (1 H, m, oc-CH) and 
8  10.23 (1H, d, NH) indicating the reformation of cyclic anhydride (51), due to loss of 
the trichloroethyl group in presence of traces of HC1 in the reaction medium (Scheme 
2.11).
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Scheme 2.11: Reformation of cyclic anhydride in presence ofHCl.
The allyl ester seemed like a possible alternative, as it can be removed under very 
mild conditions using Palladium (Pd°).
Reaction of the cyclic anhydride (51) with allyl alcohol gave the allyl ester (95) in 
94% yield, {m.p. 8 6 -8 8  °C; m/z (Found: [M + H]+, 270.0597. C9H11NO5F3 requires 
270.0589)}. Treatment of the ester with diazomethane showed two methoxy singlet 
at 8  3.71 and 8  3.80 indicating the presence of (3- and a- methyl ester in a ratio of 5:1. 
Conversion of the a-allyl ester-(3-acid (95) to a-allyl ester-p-methyl ketone (99) was 
carried out as previously described above (Scheme 2.9). Initial attempts at the 
deprotection of the a-allyl ester using palladium (Pd°) in presence of triphenyl 
phosphine and pyrrolidine has been unsuccessful.
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2.3.1 Future Work
In the protocol for the synthesis of serine described above, the Baeyer-Villiger was 
the key reaction and the most challenging step (Scheme 2.9). Various attempts to 
optimise this oxidation have so far been unsuccessful. One possible alternative which 
could be tried would be to prepare the a-p-methoxy benzyl ester. This group could 
be deprotected in presence of trifluroacetyl group by oxidative cleavage under 
essentially neutral conditions using DDQ in CH2C12.
Once optimised conditions for the Baeyer-Villiger oxidation are found, the synthesis 
of serine deuterated at C-3 starting would essentially start from C-3 [2HJ-aspartic acid 
using the same chemistry. Aspartic acid, labelled in the C-2, or either of the C-3 
positions can be readily obtained from fumaric acid. 121
Chapter Three
EXPERIMENTAL
Experimental
3.0 Experimental
Elemental microanalyses were performed in the departmental microanalytical 
laboratory.
NMR spectra were recorded on a Varian-300 (300 MHz; f.t. XH-NMR, and 74.46 
MHz; 13C-NMR), or a Varian gemini 200 (200 MHz; f.t. iH-NMR and 50.31 MHz; 
13C-NMR) spectrometers. !H-NMR spectra are described in parts per million 
downfield shift from TMS and are reported consecutively as position (8h  or 8 c), 
relative integral, multiplicity (s -singlet, d -doublet, t -triplet, q -quartet, d d -double of 
doublets, sep -septet, m -multiplet, and br -broad), coupling constant (Hz) and 
assignment (numbering according to the IUPAC nomenclature for the compound). 1H- 
NMR were referenced internally on 2HOH (4.68 ppm), CHCI3 (7.27 ppm) or DMSO 
(2.47 ppm). 13C-NMR were referenced on CH3OH (49.9 ppm), C2HCl3 (77.5 ppm), 
or DMSO (39.70 ppm). IR Spectra were recorded on a Perkin-Elmer 1710 f.t. IR 
spectrometer. The samples were prepared as Nujol mulls, solution in dichloromethane 
or thin films between sodium chloride discs. The frequencies (x>) as absorptions 
maxima are given in wavenumbers (cm1) relative to a polystyrene standard.
Mass spectra and accurate mass measurements were recorded on a VG 70-250 SE or a 
Kratos MS-50 spectrometers. Fast atom bombardment spectra were recorded using 
glycerol as a matrix. Major fragments were given as percentages of the base peak 
intensity (100%).
Flash chromatography was performed according to the method of Still et a/ .136 using 
Sorbsil C 60 (40-60 |am mesh) silica gel. Analytical thin layer chromatography was 
carried out on 0.25 mm precoated silica gel plates (Macherey-Nagel SIL g/UV254) and 
compounds were visualised using UV fluorescence, iodine vapour, ethanolic 
phosphomolybdic acid, or ninhydrin.
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Melting points were taken on an Electrothermal melting point apparatus and are 
uncorrected. Optical measurements were measured at 25 °C on a Optical Activity AA- 
100 0  polarimeter using 1 dm path length cells; [a]D values are given in deg cm2 g-1.
The solvents used were either distilled or of analar quality and light petrol ether refers to 
that portion boiling between 40 and 60 °C. Solvents were dried according to literature 
procedures, ethanol and methanol were dried using magnesium turnings. Isopropanol, 
CH2CI2 and pyridine were distilled over CaH2. THF and diethyl ether were dried over 
sodium/benzophenone and distilled under nitrogen. Thionyl chloride was distilled over 
sulfur, and the initial fractions were always discarded
p-AUyl-(2S)-aspartate hydrochloride (53)
Acetyl chloride (28 cm3, 39 mmol) was added dropwise to freshly distilled allyl alcohol 
(250 cm3) at 0 °C. The solution was stirred for 10 min at 0 °C and then for a further 1 h 
at room temperature. (2S)-Aspartic acid (13.3 g, 100 mmol) was added and the 
resulting suspension was then stirred overnight. The solution was poured into diethyl 
ether (150 cm3) and the resulting white precipitate was filtered to give the (5-allyl ester 
(14.65 g, 70%), m.p. 188-89 °C (lit. ,122 192 °C); t)max (NujolVcnr1 1756 (CO, acid) 
and 1722 (CO, ester); 8 H (200 MHz; 2H20 ) 3.06 (2 H, m, p-CH2), 4.3 (1 H, t, 
a-CH), 4.59 (2 H, m, OC//2-CH), 5.27 (2 H, m, CH=C//2) and 5.9 (1 H, m, 
C//=CH2); 8c (50.3 MHz; 2H20 ) 38.78 (P-CH2), 52.83 (a-CH), 59.58 (OCH2-CH),
121.78 (CH=CH2), 134.18 (CH=CH2), 173.54 (C02CH2) and 173.87 (C02H); m/z 
(Cl) 174 (100%, [M + H]+), 128 (2, [M - C02H]+) and 75 (12, [M + H - C4H70]+).
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p-Allyl N-Z-(2S)-aspartate (54)
P-Allyl-(25)-aspartate hydrochloride (53) (10.0 g, 47 mmol) was dissolved in water 
(200 cm3) and diethyl ether (70 cm3) was added. Potassium carbonate (10.37 g, 
75 mmol) and benzyl chloroformate (10.69 cm3, 75 mmol) were added and the 
resulting solution was stirred for 6  h. The layers were separated, and the aqueous 
layer was washed with diethyl ether (2 x 70 cm3), and then acidified with 12 mol dm 3 
hydrochloric acid. The resulting solution was extracted with diethyl ether (3 x 60 cm3), 
dried (MgS04) and concentrated under reduced pressure to give p-allyl N-Z-(2S)~ 
aspartate as a colourless oil (11.51 g, 79%); [a]D +15.8 (c 1.1, CHCI3) {lit.,122+15.3 
(c 1.1, CHCI3)}; m/z (Found: M+, 307.1063. Calc, for Ci5Hi7N 0 6: 307.1055); X)max 
neat/cm12995-3335 (br, C02H), 1731 (CO, br, acid and ester) and 1600 (C=C); §h 
(200 MHz; C2HC13) 2.9 (1 H, dd, 1 of p-CH2), 3.10 (1 H, dd, 1 of P-CH2), 4.55 
(2 H, d, OC//r CH), 4.67 (1 H, m, a-CH), 5.15 (2 H, s, OC//2Ph), 5.28 (1 H, m, 
C//=CH2), 6.45 (1 H, br s, C02H) and 7.32 (5 H, s, ArH); Sc (50.3 MHz; C2HC13)
36.93 (PCH2), 50.69 (aCH), 66.36 (OCH2-CH), 67.83 (OCH2Ph), 119.27 
(CH=CH2), 128.63 (ortho ArC), 128.74 (para ArC), 129.03 (meta ArC), 132.05 
(CH=CH2), 136.70 (quat. ArC), 156.79 (CONH), 171.27 (C 02CH2) and 175.22 
(C 02H); m/z (El) 307 (7%, M+), 262 (2, [M - C02H]+), 91 (100, C7H7+) and 41 
(37, [CH2-CH=CH2]+).
a-M ethyl-p-allyl iV-Z-(2S)-aspartate (55)
To an ice-cold solution of p-allyl N-Z-(2S)-aspartate (54) (3.0 g, 9.7 mmol) in diethyl 
ether (10 cm3) was added dropwise an excess of ethereal diazomethane. The reaction 
mixture was stirred at for 30 min and then allowed to warm to room temperature over 
1 h. Excess diazomethane was removed using a stream of nitrogen and the solvent 
was then removed under reduced pressure. The crude product was purified by silica
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chromatography using petroleum ether/ ethyl acetate (1:1) as the eluant to give the 
a-methyl ester (55) as a colourless oil (330 mg, 6 8 %); [a]D+12.0 (c 1, CH2CI2); 
m/z (Found: M+, 321.1207. Ci6H19N 0 6 requires 321.1212); Dmax (Neat)/cm-i 3403 
(NH) and 1746 (CO, acid and ester); 8 H (200 MHz; C2HC13) 2.85 (1 H, dd, 1 of 
p-C H 2), 3.09 (1 H, dd, 1 of P-CH2), 3.75 (3 H, s, OCH3), 4.55 (2 H, d, 
O C //2-CH), 4.65 (1 H, m, a-CH), 5.25 (2 H, s, OC//2Ph), 5.28 (2 H, m, 
CH=Ctf2), 5.7-5.9 (1 H, m, C//=CH2) and 7.35 (5 H, s, ArH); 8 C (50.3 MHz; 
C2HC13) 36.06 (P-CH2), 50.83 (a-CH), 53.26 (OCH3), 66.16 (OCH2-CH), 67.58 
(OCH2Ph), 119.14 (CH=CH2)> 128 55 (prtho AiQ, 128.66 (para ArC), 128.98 (meta 
aromatic), 132.08 (CH=CH2), 136.58 (quat. aromatic), 156.48 (CONH), 170.99 
(CO2CH2) and 171.68 (£ 0 2CH3); m/z (El) 321 (8 %, M+), 262 (13, [M - C 02CH3]+), 
91 (100, C7H7+) and 41 (16, C3H5+).
a-Methyl A~Z-(2S)-aspartate (56)
To a stirred solution of a-methyl P-allyl j/V-Z-(2S)-aspartate (55) (1.20 g, 3.7 mmol) in 
dichloromethane (30 cm3), under nitrogen, was added tetrakis (triphenylphosphine) 
palladium (0) (106 mg, 0.092 mmol), triphenylphosphine (60 mg, 0.233 mmol) and 
pyrrolidine (0.3 cm3, 3.6 mmol). The resulting solution was stirred at room 
temperature for 15 min, washed with 1 mol dnr3 hydrochloric acid, dried (MgS04) 
and the solvent removed under reduced pressure. The crude product was then purified 
by silica chromatography using petroleum ether/ ethyl acetate (1:1) as the eluant to give 
a-methyl N-Z-(2S)-aspartate (56) as a colourless oil, which upon standing became a 
solid (556 mg, 53%), m.p. 82-83 °C; [a]D +19.0 (c 1, CH2C12); m/z (Found: M+, 
281.0895. Ci3Hi5N 0 6 requires 281.0899); \)max (Nujol)/cm-i 3405 (NH), 3105 (br, 
-C 02H), 1736 (CO, ester), 1673 (CO, amide I band); 5h (200 MHz; C2HC13) 2.90 
(1 H, m, 1 of P-CH2), 3.10 (1 H, m, 1 of P-CH2), 3.75 (3 H, s, OCH3), 4.65 (1 H, 
m, a-CH), 5.12 (2 H, s, OC//2Ph), 5.80 (1 H, d, NH) and 7.38 (5 H, s, ArH); 5C
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(50.3 MHz; 2H20) 36.50 ((5-CH2), 50.82 (OCH3), 53.44 (a-CH), 67.81 (OCtf2Ph), 
128.55 (ortho ArC), 128.70 (para ArC), 129.05 (meta ArC), 136.44 (quat. ArC), 
158.84 (CONH), 171.88 (C02CH3) and 178.28 (C02H); m/z (El) 281 (7%, M+), 222 
(6 , [M - C02CH3]+) and 91 (100, C7H7+).
a-Methyl (2S)-aspartate (57)
To a stirred solution of a-methyl N-Z-(25)-aspartate (56) (820 mg, 2.91 mmol) in 
methanol (2 0  cm3) was added 10% palladium on activated carbon (160 mg) and the 
reaction vessel flushed with hydrogen gas. The resultant suspension was stirred 
vigorously under an atmosphere of hydrogen for 12 h. The mixture was then filtered 
through a prewashed celite pad, the solvent removed under reduced pressure, and the 
crude product recrystallised from water/ acetone, and then from water/ethanol to give 
the pure a-methyl ester (57) as a white solid (373 mg, 87%), m.p. 169-71 °C (lit. ,119 
167 °C); [a]D 38.40 (c 0.5, H20) {lit. ,119 [a]D28 +37.60 (c 0.5, H20)}; (Found: C, 
40.3; H, 6.05; N, 8.85. Calc, for C5H9N 0 4: C, 40.8; H, 6.15; N, 9.5%); 8** (200 
MHz; 2H20) 2.72 (2 H, m, |3-CH2), 3.79 (3 H, s, OCH3) and 4.23 (1 H, m, a-CH); 
Sc (50.3 MHz; 2H20 ) , 38.61 (P-CH2), 53.10 (a-CH), 53.36 (OCH3), 173.28 
(C02CH3), 178.93 (C02H); mlz (Cl) 148 (100%, [M + H]+), 132 (21, [M - CH3]+), 
102 (17, [M - C02H]+) and 88  (11, [M - C02CH3]+).
(25)-Aspartic acid P-methyl ester hydrochloride (58)
To a stirred solution of (25)-aspartic acid (10.0 g, 75.2 mmol) in dry methanol 
(45 cm3) at -10 °C was added thionyl chloride (5.49 cm3, 75.2 mmol). The solution 
was allowed to warm to room temperature and then after 30 min the solvent was 
removed under reduced pressure to half the original volume. Diethyl ether (130 cm3)
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was added, and the resulting white crystalline solid was filtered, washed with cold 
diethyl ether and dried to give the p-ester (58) (11.0 g, 80%), m.p. 189-90 °C (lit. ,122 
204 °C); [a]D+12.9 (c 1, 1:3 ethanol-water){lit. ,123 [a]D+12.4 (c 1, 1:3 ethanol- 
water)}; (Found: C, 32.5; H, 5.32; N, 7.45. Calc, for C5H10NO4Cl: C, 32.7; H, 5.5 
and N, 7.65%); 8H (200 MHz; 2H20) 3.06 (2 H, d, p-CH2), 3.67 (3 H, s, OCH3) and
4.35 (1 H, dd, a-CH); 8 C (50.3 MHz; 2H20) 38.82 (p-CH^, 52.88 (a-CH), 55.77 
(OCH3), 173.81 (C02CH3) and 174.70 (C02H).
(25)-Aspartic acid p-methyl ester (59)
(25)-Aspartic acid p-methyl ester hydrochloride (58) (6.81 g, 37 mmol) and 
propylene oxide (9.2 cm3) were refluxed in dry ethanol (140 cm3) for 3 h. On cooling, 
the precipitate was filtered, washed with diethyl ether and then recrystallised with 
ethanol/ diethyl ether to give a white solid (4.9 g, 90%), m.p. 190 °C (lit. ,125 194­
195 °C); (Found: C, 40.75; H, 6.4; N, 9.5. Calc, for C5H9N 04: C, 40.8; H, 6.15; N, 
9.5%); \)max (NujolVcm-1 3199(NH), 1761 (CO, acid) and 1741 (CO, ester); 8 H (200 
MHz; 2H20) 2.99 (2 H, m, p-CH2), 3.69 (3 H, s, OCH3) and 4.0 (1 H, dd, a-CH); 
8 C (50.3 MHz; 2H20 ) 37.27 (P~CH2), 53.47 (a-CH), 55.49 (OCH3), 175.34 
(C02CH3) and 175.68 (C02H); m/z (Cl) 148 (100%, [M + H]+), 132 (1, [M - CH3]+) 
and 102 (2, [M - C02H]+)
Dimethyl (25)-aspartate hydrochloride (60)
To a stirred solution of (25)-aspartic acid (52) (13.3 g, 0.10 mol) in dry methanol 
(70 cm3) was added dropwise thionyl chloride (10.19 cm3, 0.14 mol) at 0 °C. The 
ice bath was removed and the solution was allowed to stir at room temperature for 45 h 
and then concentrated under reduced pressure. The residual oil was triturated with
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diethyl ether and the hydrochloride salt was collected by filtration. Recrystallisation 
from ethanol/ diethyl ether gave the hydrochloride as a crystalline white solid (15.9 g, 
80%), m.p. 100-101 °C (lit. ,125 114-15 °C); [a]D+12.3 (c 1, water); (Found: C, 
36.95; H, 6.35; N, 7.05. Calc, for C6H12NC104: C, 36.45; H, 6.1; N, 7.1%); o>max 
(NujolVcm-1 3472 (NH) and 1741 (CO, ester); 5H (200 MHz; 2H20 ) 3.18 (2 H, t, 
P-CH2), 3.65 (3 H, s, p-OCH3), 3.89 (3 H, s, a-OCH3) and 4.45 (1 H, t, a-CH); 
8 C (50.3 MHz; 2H20 ) 36.56 (p-CH2), 52.06 (a-CH), 55.90 (p-OCH3), 56.85 
(a-OCH3), 172.20 (p-C02CH3) and 174.48 (a-C 02CH3); m/z (El) 162 (22%, [M - 
Cl]+), 102 (100, [M - Cl - C02CH3 - H]+) and 59 (25, C02CH3+).
(2S)-2-Ammo succinic diamide hydrochloride (61)
Dimethyl-(25')-aspartic acid hydrochloride (60) (1.00 g, 50.5 mmol) was dissolved in 
dry methanol (30 cm3). Ammonia gas was passed into the solution at 0 °C. The 
solution was then placed in a tightly stoppered vessel and allowed to warm to room 
temperature. After 45 h, the solvent was removed under reduced pressure to give the 
crude product. Recrystallisation from water/acetone gave the diamide as a white solid 
(830 mg, 98%), m.p. 214 °C (decomp.); [a]D+8.25 (c 0.4, water); m/z (Found: [M + 
H]+, 132.0770. C4H10N3O2 requires 132.0773); \)max (Nujoiycnr1 3472 & 3384 
(NH), 1692 (CO, amide I band) and 1634 (NH bending); 8h (200 MHz; 2H20) 2.70­
3.05 (2 H, m, P-CH2) and 4.25 (1 H, t, a-CH); 8 C (50.3 MHz; 2H20 ) 38.19 
(P-CH2), 52.65 (a-CH), 174.52 (P-CONH2) and 176.00 (a-CONH2); m/z (Cl) 132 
(26%, [M + H]+), 115 (6 , [M - NH2]+), 73 (5, H2NCHCONH2+), 87 (6 , [M - 
CONH2]+) and 57 (100, [CH2CONH2 + H]+).
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P-Allyl iV-Z-(2S)-aspartamide (62)
To a solution of p-allyl A-Z-(25)-aspartate (54) (200 mg, 0.65 mmol) in dry THF 
(10 cm3) was added N-methyl morpholine (71 mm3, 0.65 mmol) and the solution 
cooled to -15 °C. Isobutyl chloroformate (8 8  mm3, 0.65 mmol) was added with 
stirring and the solution left to stir at -15 °C for 30 min. The solution was filtered into a 
dry methanolic ammonia solution at -10 °C and stirring continued for 10 min. The 
solution was then allowed to warm to room temperature and stirred for a further 15 h. 
The solvent was removed under reduced pressure and the crude product was purified 
by silica chromatography using petroleum ether/ ethyl acetate (1:2) to give P-allyl N-Z- 
(2S)-aspartamide (62) as a white solid (118 mg, 62%), m.p. 86  °C; [a]D +19.3 (c 1, 
CH2C12); m/z (Found: M+, 306.1208. C15H 18N 2O5 requires 306.1215); t)max 
(Nujol)/cm-l 3423 & 3306 (NH), 1710 (CO, ester), 1673 (CO, amide I band) and 
1625 (C=C); 5h (200 MHz; C2HC13) 2.71 (1 H, m, 1 of p-CH2), 3.08 (1 H, m, 1 of 
P-CH2), 4.65 (3 H, m, a-CH and OC//2-CH), 5.19 (2 H, s, OC//2Ph), 5.21-5.40 
(2 H, m, CH=C//2), 5.60-6.15 (2 H, m, C//=CH2 and CONH), 6.52 (2 H, br s, 
CONH2) and 7.4 (5 H, s, ArH); 5C (50.3 MHz; C2HC13) 36.62 (p-CH2), 51.29 
(a-CH), 66.24 (OCH2-CH), 67.78 (OCH2Ph), 119.21 (CH=CH2), 128.65 (para 
ArC), 128.81 (ortho ArC), 129.08 (meta ArC), 132.10 (CH=CH2), 136.46 (quat. 
ArC), 156.65 (CONH), 171.90 (CO^H^ and 173.72 (CONH2); m/z (El) 306 (2%, 
M+), 91 (100, C7H7+) and 41 (8 , C3H5+).
iV2-Benzyloxycarbonyl (25)-2-amino succinic acid 1-amide (63)
To a solution of p-allyl A-Z-(2S)-aspartamide (62) (2.50 g, 8.5 mmol) in 
dichloromethane (30 cm3) under nitrogen was added tetrakis (triphenylphosphine) 
palladium (0) (245 mg, 0.21 mmol), triphenylphosphine (140 mg, 0.53 mmol) and 
pyrrolidine (0.4 cm3, 4.78 mmol). The resulting white thick solution was stirred for
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10 min, washed with 1 mol dm 3 hydrochloric acid, dried (MgS04), and concentrated 
under reduced pressure to give the crude product. Purification by silica 
chromatography using ethyl acetate/ petroleum ether (2 :1) as the eluant then gave pure 
7V2-benzyloxycarbonyl (2 S)-2 -amino succinic acid 1-amide (63) (1.5 g, 6 6 %), m.p. 
159-160 °C; m/z (Found: [M + H]+, 267.0986. C12H15N2O5 requires 267.0980); 
“Umax (Nujol)/cm_1 3403 & 3325 (NH) and 1697 (CO, amide I band); 5H (200 MHz; 
C2H30 2H) 2.78 (2 H, m, (1-CH2), 4.55 (1 H, m, a-CH), 5.19 (2 H, s, Ctf2Ph) and
7.35 (5 H, s, ArH); 8C (75.4 MHz; d6-DMSO) 36.84 ((3-CH2), 51.74 (a-CH), 65.99 
(OCH2Ph), 128.30 (para ArC), 128.37 (ortho ArC), 128.91 (meta ArC), 137.58 
(quat. ArC), 156.44 (CONH), 172.46 (CONH2) and 173.40 (C02H); m/z (Cl) 267 
(100%, [M + H]+), 223 (3, [M + H - CONH2]+) and 91 (12, C7H7+).
(2S)-2-amino succinic acid 1-amide (Isoasparagine) (64)
To a solution of A^-benzyloxycarbonyl (2S)-2-amino succinic acid 1-amide (6 6 6  mg,
2.5 mmol) in methanol (30 cm3) was added 10% palladium on activated carbon 
(120 mg) and the reaction vessel flushed with hydrogen gas. The resultant suspension 
was stirred vigorously under an atmosphere of hydrogen for 16 h. The mixture was 
then filtered through a prewashed celite pad. The pad was washed with methanol 
(15 cm3), water (2 0  cm3) and the solvent removed under reduced pressure to give the 
crude amide (64). Recrystalization from water/ethanol then gave the pure (2S)-2- 
amino succinic acid 1-amide (64) (250 mg, 75%), m.p. 214-216 °C (decomp.) 
{lit. ,118 m.p. 212-214 °C (decomp.)}; [a]D+16.7 (c 1.8, 0.1 mol dm-3 HC1) {lit. ,118 
[a ]D26 +15.4 (c 1.8, 0.1 mol dm-3 HC1)}; (Found: C, 31.75; H, 6.7; N, 18.15. Calc, 
for C4H8N20 3.H20: C, 32.0; H, 6.7; N, 18.7%); 8H (200 MHz; 2H2G) 2.65 (2 H, m, 
P-CH2) and 4.10 (1 H, m, a-CH); 5C (50.3 MHz; 2H20 ) 39.52 (P~CH2), 53.32 
(a-CH), 174.76 (CONH2) and 178.99 (C02H); mtz (Cl) 133 (100%, [M + H]+), 115 
(5, [M - NH3]+), 88  (2, [M - C02H]+) and 73 (9, [M - CH2C02H]+).
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A-Benzyloxycarbonyl-(2S)-asparagine (68)
0
II
ifY
co2h
^ nh2
(2S)-Asparagine (10.0 g, 75.8 mmol) was dissolved in water (350 cm3) and the pH of 
the solution adjusted to 8 with the slow addition of sodium bicarbonate (15.9 g, 
190 mmol). The solution was then vigorously stirred while benzylchloroformate 
(12.9 cm3, 91 mmol) was added in five portions over 20 min. After overnight 
stirring, the solution was extracted with ether (2 x 75 cm3) and the aqueous phase was 
acidified with 12 mol dm-3 hydrochloric acid. The resultant precipitate was filtered and 
recrystallised from ethanol/ether to give white shiny needle shaped crystals (15.8 g, 
78%), m.p. 160-62 °C (decomp.) {lit. ,137 165 °C (decomp.)}; [cc]D +6.4 (c 1.6, 
AcOH) {lit. ,137 [a]D +7.8 (c 1.6, AcOH)}; \)max (Nujoiycnr1 3337 (N-H) and 1669 
(C=0); SH (200 MHz; 2H20), 2.40-2.80 (2 H, m, |5-CH2), 4.25 (1 H, m, a-CH),
5.1 (2 H, s, C //2Ph) and 7.37 (5 H, s, ArH); 8 C (74.46 MHz; d6-DMSO), 36.7 
(P-CH2), 50.6 (a-CH), 65.4 (CH2Ph), 127.6, 127.7 {ortho, para ArC), 128.2 (ArC),
155.7 (ArCO), 171.1 (C02H) and 172.9 (CONH2); m/z (El) 249 (72%, [M - NH3]+) 
and 91 (100, C7H7+).
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iV2-Benzyloxycarbonyl-(2S)-2,3-diaminopropanoic acid (69)
N-Benzyloxycarbonyl-(2S)-asparagine (6 8 ) (6.0 g, 22.6 mmol) was added to the 
stirred solution of bis [trifluoroacetoxy]-phenyl iodine (14.6 g, 33.9 mmol) in N>N- 
dimethyl formamide/water (180 cm3, 1;1 v/v) at room temperature. After 15 min, 
pyridine (3.6 cm3, 45.3 mmol) was added and stirring continued overnight. The 
solvent was removed by distillation under reduced pressure and the resulting oil 
dissolved in water (60 cm3). The solution was extracted with ether (2 x 70 cm3) and 
the aqueous phase concentrated under reduced pressure to give a yellow oil. Tituration 
with ethyl acetate resulted in the precipitation of the product, which was then 
recrystallised from water to give a white shiny crystals (3.42 g, 64%), m.p. 230­
232 °C {lit. ,129 m.p. 228-230 °C (decomp.)}; [a]D -6.9 {c 0.4, 1 mol dm 3 NaOH) 
{lit. ,129 [a]D -7.8 (c 0.4, 1 mol dm-3 NaOH)}; m/z (Found: M+, 238.0957. Calc, for 
CiiHi4N20 4: 238.0953); 0)max (Nujoiycm1 3302 (N-H) and 1694 (C=0); 5h (200 
MHz; 2H20) 2.65-3.0 (2 H, m, p-CH2), 3.95 (1 H, q, a-CH), 5.1 (2 H, s, C//2Ph) 
and 7.40 (5 H, s, ArH); 8 C (74.46 MHz; 2H20  + NaOD) 44.80 (p-CH2), 56.02 
(a-CH), 63.99 (OCH2Ph), 127.65, 128.01 & 128.93 {ortho and para ArC), 140.48 (q 
ArC), 166.06 (CONH) and 179.69 (C02H); m/z (El) 238 (4%, M+) and 91 (100, 
C7H7+).
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iV2»3-BenyloxycarbonyI-(2S)-2,3-diaininopropanoic acid (70)
Into boiling water (450 cm3) was added AT2-benzyloxycarbonyl-(25)-2,3-diamino 
propanoic acid (3.0 g, 12.6 mmol). The clear solution was allowed to cool to 60 °C 
and then NaHC03 (2.64 g, 31.5 mmol) was added carefully untill the pH of the 
solution was 8 . Benzylchloroformate (2.15 cm3, 15.1 mmol) was added to the 
vigorously stirring solution over 30 min at 60 °C, and stirring continued at room 
temperature for 6  h. The mixture was extracted with ether (2 x 75 cm3), the aqueous 
phase was acidified with 12 mol dnr3 HC1 and again extracted with ether (3 x 60 cm3). 
The ethereal layers were combined, dried (MgSO^ and the solvent was removed under 
reduced pressure to give an oil. The crude was purified by silica column 
chromatography using ethyl acetate/petether (1:1) as the eluant to give a white solid 
(4.29 g, 92%), m.p. 96-97 °C; [a]D +40 (c, 0.33, CH2C12); m/z (Found: [M + H]+, 
373.1387. C19H21N20 6 requires 373.1399); 5H (200 MHz; C2HC13) 3.60 (2 H, m, 
p-CH2), 4.45 (1 H, m, a-CH), 5.03-5.07 (4 H, d, 2 x Ctf2Ph), 5.82 (1 H, t, 
CH2N//CO), 6.25-6.28 (1 H, d, C 02N//CH), 7.28-7.30 (10 H, d, ArH) and 8.17 
(1 H, br, s, C 02H); 5c (50.3 MHz; C2HC13) 42.97 (p-CH2), 55.15 (a-CH), 67.78 
(CH2Ph), 128.64, 128.74, & 129.04 {ortho and para ArC), 136.78 (q ArC), 157.16 
(CONH), 158.05 (CONH) and 173.84 (C02H); m/z (Cl) 373 (29%, [M + H]+) and 
329 (100, [M + H - C02]+).
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jV2’3-BenzyloxycarbonyI-(2S)-2,3-diaminopropanoic acid methyl ester 
(75)
To a stirred solution of iV2'3-Benzyloxycarbonyl-(2S')-2,3-diamino propanoic acid, 
(70) (500 mg, 1.34 mmol) in dry methanol (30 cm3) was added dropwise thionyl 
chloride (0.12 cm3) at 0 °C. The ice bath was removed and the solution allowed to 
warm to room temperature and then refluxed for 3 h. The solvent was then removed 
under reduced pressure to give the crude product. Purification by silica column 
chromatography using pet. ether /ethyl acetate (1:1) as the eluant gave the pure ester 
(75) as a white crystalline solid (300 mg, 58%), m.p. 71-72 °C; [a]D +12.0 (c 0.5, 
CH2C12); (Found: C, 61.9; H, 5.8; N, 7.15. C20H22N2O6 requires C, 62.2; H, 5.75; 
N, 7.25%); 6 h (300 MHz; C2HC13) 3.61-3.63 (2 H, d, p-CH2), 3.72 (3 H, s, OCH3), 
4.42-4.44 (1H, d, a-CH), 5.07-5.10 (4 H, d, C //2Ph), 5.16 (1 H, s, br, 
CH2N//CO), 5.78 (1 H, s, br, C02N//CH) and 7.32-7.34 (10 H, d, ArH); 8C (74.46 
MHz; C2HC13) 42.90 (|3-CH2), 52.95 (OCH3), 54.95 (a-CH), 67.30 & 67.4 (2 x 
CH2Ph), 128.53, 128.60 & 128.94 (ArC), 136.63 & 136.77 (ArC), 156.70 (NHCO),
157.43 (CONH) and 171.54 (C02CH3); m/z (El) 387 (18%, [M + H]+), 327 (8 , [M - 
C 02CH3]+), 251 (8 , [M - C6H6C 02]+), 223 (23, [M + H - C6H5C 02NHCH2]+) and 
91 (100, C7H7+).
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N2>3-BenzyloxycarbonyI -(2S)-2,3-diamino propane-l-ol (71)
0
II 011
( | T  ° “  °~  NVH NH-
uhoh2c
To a stirred solution of A ’^3-Benzyloxycarbonyl-(25)-2,3-diamino propanoic acid 
(3.0 g, 8.06 mmol) in dry THF (60 cm3) at -30 °C was added N-methylmorpholine 
(0.88 cm3, 8.06 mmol) and isobutyl chloroformate (1.04 cm3, 8.06 mmol) 
respectively. A white precipitate formed very quickly and after 30 min the mixture was 
filtered into a solution of NaBH4 (182.84 mg, 4.84 mmol) in dry THF (20 cm3) at 
-30 °C. The reaction was stirred at this temperature for 3 h and then left stir overnight 
at room temperature. Water (30 cm3) was addded carefully to the reaction mixture and 
the solution was concentrated under reduced pressure until the water started to distill 
off. The aqueous solution was extracted with ether (3 x 70 cm3) and the ethereal layers 
were combined, washed with brine, dried (MgS04), and concentrated under reduced 
pressure to give the crude product as a solid. Purification by silica coloumn 
chromatography using ethyl acetate/ pet. ether (1:1) as the eluant gave a white solid 
(1.96 g, 6 8 %), m.p. 105-106 °C; [a]D +8.2 (c 1, CH2C12); (Found: C, 6.3; H, 63.35; 
N, 7.75%. Calc, for C19H22N20 5: C, 6.2; H, 63.7 and N, 7.8%); m/z (Found: [M + 
H]+ 359.1608. Calc, for C19H23N20 5: 359.1607); 8 H (300 MHz; C2HC13) 3.20­
3.70 (6  H, m, (3-CH2, a-CH & CH2OH), 5.07-5.10 (4 H, d, 2 x C i/2Ph), 5.40­
5.45 (1 H, t, N//CH2), 5.49-5.51 (1 H, d, N//CH) and 7.33-7.34 (10 H, d, ArH); 
8 C (74.46 MHz; C2HC13) 40.69 (p-CH2), 52.56 (a-CH), 61.38 (CH2OH), 66.77 &
67.15 (2 x CH2Ph), 127.90, 128.00, 128.05, 128.19, 128.40 & 128.45 (ArC), 
135.90 & 136.08 (q ArC), and 156.21 & 157.91 (2 x CONH); m/z (Cl) 359 (41%, 
[M + HJ+), 341 (3, [M + H - H20 ]+), 251 (100, [M - C6H6CH20 ]+), 207 (6 , [M + H 
- C6H5C02NH]+) and 91 (37, C7H7+).
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2,3-Diaminopropane-l-ol (66)
h2n
H....
C\JIz'l
j m
hoh2c
To a solution of A ’^3-Benzyloxycarbonyl-(25)-2,3"diaminopropane-l-ol (1.42 g, 
3.96 mmol) in methanol (70 cm3) was added 10% palladium on activated carbon 
(500 mg) and the reaction vessel flushed with hydrogen gas. The resultant mixture 
was stirred vigorously under an atmosphere of hydrogen and the progress of the 
reaction followed by t.l.c. After 16 h, the solution was filtered through prewashed 
celite pad, and the celite pad washed with methanol (20 cm3). The filtrate was 
concentrated under reduced pressure to give 2,3-diamino-1-propanol as an oil (330 mg, 
93%), [a]D +9.5 (c 2, MeOH); 5h (200 MHz; 2H20) 2.45-2.93 (3 H, m, a-CH & 
p-CH2) and 3.38-3.63 (2 H, m, Gtf2OH); 8 C (50.3 MHz; 2H20 ) 46.21 (p-CH2),
56.16 (a-CH) and 66.81 (CH2OH); m/z (El) 92 (76%, [M + 2H]+), 72 (7, [M- 
H20 ]+), 60 (100, C2H6NO+) and 59 (23, [M - CH2OH]+).
2.3-Diaminopropane-l-ol dihydrochloride salt (73)
2.3-Diaminopropane-l-ol (6 6 ) (300 mg, 3.32 mmol) was dissolved in methanol 
(15 cm3) and the solution cooled to at 0 °C. HC1 gas was bubbled through the 
solution for 10 min. The solvent was then removed reduced under pressure to give the 
crude hydrochloride salt, which was recrystallisation from water/ ethanol to give a pale 
yellow solid (240 mg, 44%), m.p. 180-81 °C (lit. ,127 172-74 °C); [a]D +23.93 (c
t
0.33, H20); m/z (Found: [M + H - 2HC1]+, 91.0869. C3Hu N20  requires 91.0871); 
5h (200 MHz; 2H2Q) 3.33 (2 H, m, C//2NH2) 3.67-3.81 (1 H, m, a-CH) and 3.82-
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4.0 (2 H, m, 0 / 2OH); 8 c (50.3 MHz; 2H20 ) 41.31 (CH2NH2), 52.88 (a-CH) and
61.93 (CH2OH); m/z (Cl) 129 (1.5%, [M + H - Cl]+) and 91 (100, [M + H - 2HC1]+].
2,3-DiaminopropyI hydrogen sulfate hydrochloride (74)
To a cooled suspension of 2,3-diamino propanol (6 6 ) (50 mg, 0.55 mmol) in 
dichloromethane (15 cm3) was added dropwise, and then more rapidly a cooled mixture 
of chlorosulfonic acid (0.05 cm3, 0.83 mmol) in dichloromethane (1 cm3). The ice bath 
was removed and the reaction mixture was allowed to stir at room temperature for 45 h. 
The solvent was removed under reduced pressure to give the 2,3-diaminopropyl 
hydrogensulfate as a hydrochloride salt. Recrystallisation from water/ ethanol gave a 
white solid (80 mg, 59%), m.p. 55-60 °C; [a]D +9.57 (c 1.17, H20); 8C(50.3 MHz; 
2H20 )  40.57 (p-CH^, 50.72 (a-CH) and 67.44 (CH20 S 0 3H); m/z (Cl) 171 (3.5%, 
[M - 2HC1]+), 111 (30, CH2O S 0 3H+), 97 (27, OS03+), 73 (100, [M - 2HC1 - 
OS03H]+) and 60 (11, [M + H - HC1 - CH20 S 0 3H]+).
a-Isopropyl-iV-trifluroacetyI-(2S)-aspartate (77)
To a suspension of (2S)-aspartic acid (5 g, 37 mmol) in dry THF (60 cm3) at 0 °C, 
under an atmosphere of nitrogen, was added dropwise trifluoroacetic anhydride 
(21.18 cm3, 0.15 mmol) over 30 min. The reation mixture was allowed to stir at 0 °C 
for 1 h and then at room temperature for a further 2  h during which time dissolution 
was completed. The solvent was removed under reduced pressure to give the 
anhydride as a white solid. The anhydride was treated with dry isopropanol (70 cm3)
f
and the solution stirred at 40 °C for 12 h under nitrogen. The solvent was removed 
under reduced pressure to give the crude isopropyl ester. Recrystallisation from diethyl 
ether/ pet. ether gave pure a-wopropyl-N-trifluroacetyl-(2S)-aspartate (9.8 g, 97%);
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m.p. 98.2 °C (lit. ,137 88-90 °C); [a]D +40.6 (c 0.5, CH2C12); (Found; C, 39.9; H, 
4.65; N, 5.1. Calc, for C9H12N 0 5F3: C, 39.85; H, 4.46; N, 5.15%); m/z (Found: [M 
+ H]+, 272.0736. Calc, for C9H13N 0 5F3: 272.0745); umax (Nujol)/cm-i 3320 (NH 
str), 1760 (ester C=0), 1745 (acid C=0) and 1710 (trifluoroacetyl C=0); 5H (200 
MHz; C2HC13) 1.21-1.30 (6  H, dd, 2 x CH(C//3)2), 2.93-3.23 (2 H, dd, p-CH2),
4.78 (1 H, m, a-CH), 5.11 (1 H, m, C//(CH3)2), and 7.36 & 7.37 (1 H, dd, NH); 
§c (50.3 MHz; C2HC13) 21.40 &21.54 (2 x CH(CH3)2), 35.25 (P-CH2), 48.88 
(a-CH), 71.03 (CH(CH3)2), 168.46 (CONH), 168.49 (CO^Pr), and 175.73 (C02H); 
m /z (El) 272 (42%, [M + H]+), 226 (13, [M - C 02H]+), 212 (53, [M - 
OCH(CH3)2]+), 184 (100, [M - C02CH(CH3)2]+), 166 (6 6 , [M - C 02CH(CH3) 2 - 
H20 ]+), 139 (90, [M - C02CH(CH3) 2 - C02H]+) and 43 (98, C3H7+).
a-/sopropyl-iV-trifIuoroacetyI-(25)-aspartyl-P-acid chloride (78)
To a stirred solution of a-isopropyl-N-trifluroacetyl-(25)-aspartic acid (5 g,
18.44 mmol) in dry dichloromethane (20 cm3) was added distilled thionyl chloride 
(5.36 cm3, 73.6 mmol) and the mixture was reflux for 12 h under nitrogen. The 
solvent was then removed under reduced pressure to yield the {3-acid chloride (4.05 g, 
76%), m,p. 120-123 °C (lit. ,138 123-5 °C); [a]D +65.4 (c 0.63, CH2C12) (lit. ,138
[a]D +65.8 (c 0.63, CH2C12)}; \)max (Nujol)/cm_1 3327 (NH str), 1806 (acid chloride 
C=0), 1733 (ester 0=0), and 1710 (trifluoroacetyl C=0); 8h (200 MHz; C2HC13) 1.3 
(6  H, dd, 2 x CH(C//3)2), 3.62 (2 H, m, P-CH2), 4.7 (1 H, m, a-CH), 5.15 (1 H, 
m, C//(CH3)2) and 7.36 & 7.37 (1 H, br., NH); 6 C (50.3 MHz; C2HC13) 21.46 & 
21.56 (2 x CH(CH3)2), 47.4 (P~CH2), 49.4 (a-CH), 71.65 (CH(CH3)2), 157.40 
(CONH, /  37), 167.79 (CO^Pr) and 172.35 (COC1).
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/sopropyl 5-diazo-4-oxo-A-trifluoroacetyI-(2S)«norvaIinate (79)
A solution of wopropyl iV-trifluoroacetyl-(2.S)-aspartyl-(3-chloride (78) (3 g, 10.35 
mmol) in diethyl ether (40 cm3) and tetrahydrofuran (10 cm3) was added dropwise to 
excess ethereal diazomethane (175 cm3) over 30 min, at 0 °C with stirring. The 
solution was allowed to warm to room temperature during 90 min after which time 
excess diazomethane was removed using a stream of nitrogen. The solvent was then 
removed under reduced pressure to give a pale yellow solid which was recrystallised 
from diethyl ether/ cyclohexane to give yellow crystals of the diazoketone (2.90 g, 
95%), m.p. 91-93 °C; [a]D +22.8 (c 1, CH2C12); m/z (Found: [M + H]+ 296.0856. 
C i0H 13N 3O4F3 requires 296.0858); a)max (Nujol)/cm_1 3316 (NH str), 2126 
(diazoketone CHN2), 1746 (ester 0=0), 1710 (trifluoroacetyl C=0) and 1644 (diazo 
C=0); 5h (300 MHz; C2HC13) 1.21-1.25 (6  H, dd, 2 x CH(C//3)2), 2.85-3.09 (2 H, 
dd, P-CH2), 4.69 (1 H, m, a-CH), 5.05 (1 H, m, C//(CH3)2), 5.32 (1 H, s, CHN2) 
and 7.38-7.41 (1 H, d, NH); 5c (74.46 MHz; C2HC13) 21.48, 21.56 (2 x CH(CH3)2), 
40.28 (P-CH2), 49.26 (a-CH), 55.60 (CHN2), 70.48 {OCH(CH3)2}, 157.39 
(CF3CONH), 168.75 (COCH(CH3)} and 191.46 (COCHN2); m/z (El) 296 (44%, [M 
+ H]+), 268 (32, [M + H - N2]+), 226 (100, [M - COCHN2]+) and 113 (35, [M + H - 
CF3CONH)]+).
/sopropyl 4-oxo-A-trifluoroacetyl-(2S)-norvalinate (80)
Aqueous HI (55%; excess) was added dropwise to a stirred solution of the diazoketone 
(79) (2.80 g, 9.5 mmol) in dichloromethane (40 cm3). After 15 min the organic layer 
was washed with water (2  x 10  cm3), dilute aqueous sodium thiosulfate (until 
colourless), water (5 cm3) and then dried (Na2SC>4). The solvent was removed under 
reduced pressure to yield the ketone. Recrystallised from diethyl ether/pet. ether gave 
the ketone as white crystals (2.0 g, 78%), m.p. 50-52 °C; (Found: C, 44.45; H, 5.3;
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N, 5.22. C10H 15NO4 F3 requires C, 44.6; H, 5.25; N, 5.2%); [<x]D 4-37.2 (c 0.5, 
CH2Cl2); m/z (Found: [M 4- H]+, 270.0962. C10H15NO4F3 requires 270.0953); \)max 
(Nujol)/cm-1 3307 (NH str), 1739 (ester C=0), and 1710 (trifluoroacetyl C=0 and 
ketone C=0 ); 8 h (2 0 0  MHz; C2HC13) 1.19-1.27 (6  H, dd, 2  x CH(C//3)2), 2.18 
(3 H, s, CH3), 2.95-3.35 (2 H, ABX, (5-CH2), 4.63-4.71 (1 H, q, a-CH), 4.99-5.12 
{1 H, sp, OC//(CH3)2) and 7.38-7.41 (1 H, d, NH); 5C (74.76 MHz; C2HC13)
21.45 & 21.52 (2 x CH(C//3)2), 29.77 (COCH3), 43.90 (P-CH2), 48.73 (a-CH),
70.43 (OCH(CH3)2), 168.83 (C02iPr)) and 206.39 (COCH3); m/z (El) 270 (7%, [M 
4- H]+), 226 (16, [M - COCH3]+), 212 (13, [M - CH2COCH3]+), 210 (18, [M - 
OCH(CH3)2]+), 182 (36, [M - C02CH(CH3)2]+), 59 (11, [OCH(CH)2]+) and 43 
(100, [CH(CH3)2]+).
4-Oxo-(25)-norvaline (92)
To a solution of /sopropyl 4-oxo-/V-trifluoroacetyl-(25)-norvalinate (80) (100 mg, 
0.37 mmol) in methanol (0.91 cm3) was added 1 mol dm-3 NaOH (1 cm3). The 
resulting mixture was stirred at room temperature for 1 h and then after the addition of 
1 mol dm'3 HC1 (1 cm3) the solvent was removed under reduced pressure to give crude
92. 8h (200 MHz; 2H20) 2.22 (3 H, s, COCH3), 3.18 (2 H, m, p-CH2), 4.78 (2 H, 
q, OCH2) and 3.95 (1 H, a-CH); 8 C (74.46 MHz; 2H20 )  29.41 (CH3), 42.87 
(P-CHJ, 50.25 (a-CH), 173.90 (C02H) and 211.23 (COCH3);
a-TrichloroethyI-/V-trifluroacetyl-(2S)-aspartate (93)
/
To a suspention of (2S)-aspartic acid (100 mg, 0.75 mmol) in dry THF (15 cm3) at 
0 °C under an atmosphere of nitrogen was added dropwise trifluroacetic anhydride 
(0.42 cm3, 3.0 mmol). The reaction mixture was allowed to stir at 0 °C for 1 h and
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then at room temperature for a further 2 h, during which time dissolution was 
completed. The solvent was removed under reduced pressure to give the anhydride as 
a white solid. The anhydride was treated with dry 2,2,2-trichloroethanol (15 cm3) and 
the solution stirred at 50 °C for 16 h under nitrogen. The solvent was removed under 
reduced pressure to give the crude ester. Recrystallization from ether/pet. ether gave a 
white solid (50 mg, 50%), m.p. 123-25 °C; mlz (Found: [M + H]+, 359.9425. 
C8H8N0 5 F3Cl3requires 359.9420); dH (200 MHz; C2HC13) 2.99-3.35 (H, m, p- 
CTy, 4.82 (2 H, q, OCH2), 5.05 (1 H, pen., a-CH), 7.46 (1 H, d, NH) and 8.18 (1 
H, br, C 02H); 8c (74.76 MHz; d6-DMSO) 34.50 (p-CH2), 49.79 (a-CH), 74.45 
(OCH2), 95.31 (CC13), 116.38 (CF3, q, /  286.33), 156.84 (CONH, q, /  24.65), 
171.51 (C02CH2CC13) and 171.91 (C02H); mlz (El) 360, 362, 364 & 366 (3:3:2:1) 
(1%, M+), 212 (17, [M - OCH2CCl3]+) and 184 (100, [M - C02CH2CC13]+).
a-Trichloroethyl-p-methyl-A-trifluoroacetyl aspartic acid (94)
This was prepared in an identical manner to a-allyl P~methy 1-JV-trifluoroacetyl aspartic 
acid (96) using a-trichloroethyl-iV-trifluroacetyl aspartic acid (93) in 80% yield; 5H 
(200 MHz; C2HC13) 2.89-3.29 (2 H, dd, P-CH2), 3.71 (3 H, s, p-OCH3), 4.78 
(2 H, q, OCH2), 5.01 (1 H, a-CH) and 7.60 (1H, d, NH); 5C (50.3 MHz; C2HC13)
33.45 (P-CH2), 49.10 (a-CH), 52.99 (OCH3), 74.54 (OCH2), 107.88 (CC13), 
168.09 (C02CH3) and 171.54 (C02CC13).
a-AUyl-iV-trifliiroacetyl-(25)-aspartate (95)
To a suspention of (2S)-aspartic acid (2 g, 15 mmol) in dry THF (40 cm3) at 0 °C 
under an atmosphere of nitrogen was added dropwise trifluroacetic anhydride 
(8.46 cm3, 60 mmol) over 30 min. The reation mixture was allowed to stir at 0 °C for
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1 h and then at room temperature for a further 2  h, during which time dissolution was 
completed. The solvent was removed under reduced pressure to give the anhydride as 
a white solid. The anhydride was treated with dry allyl alcohol (45 cm3) and the 
solution stirred at room temperature for 16 h under nitrogen. The solvent was removed 
under reduced pressure to give the crude allyl ester. Purification by column 
chromatography using ethyl acetate/pet. ether (1:1) as the eluant gave a white solid 
(3.8 g, 94%), m.p. 8 6 -8 8  °C; [a]D +27.4 (c 1, CH2C12); m/z (Found: [M + HJ+, 
270.0597. C9H11NO5F3 requires 270.0589); 'Omax (Nujol)/cm-i 3296 (NH str), 1751 
(ester C=0), and 1717 (trifluoroacetyl C=0); §h (200 MHz; C2HC13) 2.95-3.27 (2 H, 
ABX, p-CH2), 4.62-4.72 (2 H, m, OCH2), 4.80-4.95 (1 H, m, a-CH), 5.27-5.39 
(2 H, m, CH=C//2), 5.80-5.99 (1 H, m, CH=CH2), 7.39-7.43 (1 H, d, NH) and
9.43 (1 H, br, C 02H); 8 C (74.76 MHz; C2HC13) 35.16 (P-CH2), 48.73 (a-CH), 
67.23 (OCH2), 115 (CF3), 119 (CH=CH2), 130.85 (CH=CH2), 157.50 (CONH), 
168.82 (C02CH2) and 175.68 (C02H); m/z (Cl) 270 (100%, [M + H]+).
a-AUyl p-methyl iV-trifluoroacetyl aspartic acid (96)
To a stirred solution of the a-allyl AZ-trifluroacetyl aspartic acid (95) (150 mg,
0.53 mmol) in ether was added slowly, dropwise ethereal diazomethane at 0 °C. After 
the addition was complete, the ice bath was removed and the reaction mixture was 
stirred at room temperature for 2 h. Excess diazomethane was flushed with N2 and the 
solvent was removed under reduced pressure to give the crude a-allyl p-methyl aspartic 
acid ester. Purification by silica chromatography using ethyl acetate/ pet. ether (1:1) as 
the eluant gave white crystals (130 mg, 83%), m.p. 57-61 °C; (300 MHz; C2HC13)
2.84-3.22 (2 H, dd, P-CH2), 3.70 (3 H, s, p-OCH3), 4.58-4,69 (2 H, m, 
OC//2-CH), 4.85-4.87 (1 H, m, a-CH), 5.24-5.38 (2 H, m, CH=CH2\  5.81-5.93 
(1 H, m, C//=CH2) and 7.52 (1 H, d, NH); 5C (50.3 MHz; C2HC13) 35.67 (P-CH2),
49.35 (a-CH), 52.82 (OCH3), 67.41 (OCH2-CH), 119.78 (CH=CH2), 131.39
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(CH=CH2), 157.68 (CONH), 169.21 (CC^CH^ and 171.54 (C02CH3); m/z (El) 283 
(1%, M+), 252 (3, [M - OCH3]+), 242 (2, [M - C3H5]+), 238 (4, [M - CH2OCH3]+), 
224 (23, [M - C02CH3]+), 198 (100, [M - C02C3H5]+) and 41 (92, C3H5+).
a-AIlyI-/V-trifluoroacetyl-(25)-aspartyl-P-aeid chloride (97)
To a stirred solution of a-allyl-/V-trifluroacetyl-(2S,)-aspartic acid (95) (3.8 g, 
14.11 mmol) in dry dichloromethane (20 cm3) was added distilled thionyl chloride 
(3.08 cm3, 42.33 mmol) and the mixture was reflux for 12 h under nitrogen. The 
solvent was removed under reduced pressure to yield the crude acid chloride (3.8 g, 
94%), m.p. 89-90 °C; \)max (Nujoiycm1 3325 (NH str), 1819 (acid chloride C=0), 
1741 (ester C=0) and 1712 (trifluoroacetyl C=0); 6h (300 MHz; C2HC13) 3.53-3.69 
(2 H, m, p-CH^, 4.56-4.70 (2 H, m, OCH2), 4.77-4.82 (1 H, m, a-CH), 5.26-5.37 
(2 H, m, CH=C//2),5.81-5.94 (1H, m, CH=CU2) and 7.38 (1 H, d, NH); 8C (74.76 
MHz; C2HC13), 47.40 (P-CH2), 49.33 (a-CH), 67.65 (OCH2), 115.48 (CF3, q, /  
286.5), 120 (CH=CH2) 130.56 (CH=CH2), 157.33 (CONH, J 37), 167.79 
(C020CH2) and 172.25 (COC1); m/z (El) 288 and 290 (4 and 1.3%, chlorine isotopes, 
[M + H]+), 252 (26, [M - Cl]+), 224 (86, [M - COCl]+), 202 (37, [M - C 02C3H5]+) 
and 41 (100, C3H5+).
a-AUyl 5-diazo-4-oxo-/V-trifIuoroacetyl-(2S)-norvalinate (98)
To a stirred solution of the a-allyl iV-trifluoroacetyl-(2S)-aspartyl-P-chloride (97) 
(3.7 g, 12.86 mmol) in diethyl ether (40 cm3) and tetrahydrofuran (10 cm3) was added 
dropwise an excess of freshly prepared ethereal diazomethane (170 cm3 ) over 30 min 
at 0 °C. The solution was allowed to warm to room temperature during 90 min after 
which time excess diazomethane was removed using a stream of nitrogen. The solvent
82
Experimental
was then removed under reduced pressure to give a pale yellow solid which was 
recrystallised from diethyl ether/ petether to give yellow crystals of the diazoketone 
(3.5 g, 93%), m.p. 53-54 °C; 8 h (300 MHz; C2HC13) 2.87-3.27 (2 H, ABX, p-CH^, 
4.61-4.68 (2 H, m, OCH2), 4.80-4.82 (1 H, m, a-CH), 5.25-5.35 (2 H, m, 
CH=C//2), 5.82-5.95 (1 H, m, 0 /= C H 2) and 7.64 (1 H, d, NH); 5C (74.76 MHz; 
C2HC13) 40.27 (P-CH2), 49.09 (a-CH), 55.81 (CHN^,66.91 (OCH2), 115.72 (CF3, 
q, J 286.5), 119.28 (CH=CH2), 131.20 (CH=CH2), 156.15 (CF3CONH, q, J  37.5),
169.05 (C02CH2) and 191.46 (COCHN^.
a-Allyl 4-OxO“iV-trifluroacetyl-(25)-norvalinate (99)
Aqueous HI (55%; excess) was added dropwise with stirring to a solution of the 
diazoketone (70) (2.50 g, 8.52 mmol) in dichloromethane (40 cm3). After 15 min the 
organic phase was washed with water (2  x 10 cm3), dilute aqueous sodium thiosulfate 
(until colourless), water (5 cm3) and then dried (NaS04). The solvent was removed 
under reduced pressure to yield a yellow solid which was recrystallised from diethyl 
ether/ pet. ether to give white crystals (1.90 g, 84%), m.p. 53-54 °C; [a]D +39.3 (c 1, 
CH2C12); m/z (Found: [M - C3H5]+, 226.0336. C7H7NO4F3 requires 226.0327); a)max
(Nujol)/cm_1 3336 (NH str), 1748 (ester C=0) and 1722 (trifluoroacetyl C=0 and 
ketone 0=0); 8H(300 MHz; C2HC13) 2.18 (3 H, s, CH3), 2.98-3.35 (2 H, ABX, 
P-CH2), 4.58-4.66 (2 H, m, OCH2), 4.68-4.78 (1 H, m, a-CH), 5.23-5.34 (2 H, m, 
CH=C//2), 5.79-5.92 (1 H, m, C//=CH2) and 7.43-7.45 (1 H, d, NH); 8 C (74.76 
MHz; C2HC13) 29.77 (COCH3), 43.90 (p~CH2), 48.86 (a-CH), 66.85 (OCH2),
115.7 (CF3, q, /  285.75), 119.35 (CH=CH2), 131.15 (CH=CH2), 157.132 (CONH, 
q, J 37.5), 169.15 (C02CH2) and 206.55 (COCH3); m/z (El) 267 (1%, M+), 226 (12, 
[M - C3H5]+), 43 (100, [M - COCH3]+) and 41 (45, C3H5+).
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